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Referat
Die Behandlung von Patienten mit Tumoren im Kopf-Hals-Bereich gestaltet sich als komplexer
und herausfordernder Prozess sowohl für den Patienten als auch für die behandelnden Ärzte und
Chirurgen. Zur Gewährleistung der bestmöglichen individuellen Therapie werden vor Beginn der
Behandlung zahlreiche diagnostische Verfahren durchgeführt. Hierzu zählen unter anderem medizi-
nische bildgebende Verfahren wie z.B. Computertomographie (CT) oder Magnetresonanztomogra-
phie (MRT) sowie die Entnahme von tumorverdächtigem Gewebe während einer Panendoskopie
zur exakten Bestimmung der Tumorart (Histologie, Grading, TNM-Klassifikation nach UICC, ge-
naue Lokalisation des Primärtumors, der lokoregionären Metastasen und ggf. Fernmetastasen). Die
gewonnenen Informationen bilden anschließend die Grundlage für die Entscheidung über die durch-
zuführende Therapie und stehen in unterschiedlichen klinischen Informationssystemen sowie auf
Papierakten zur Verfügung. Leider werden die Daten im klinischen Alltag häufig nur unstruktu-
riert und schwer auffindbar präsentiert, da die führenden Informationssysteme nur unzureichend in
den klinischen Arbeitsprozess integriert und untereinander schlecht vernetzt sind. Die präzise und
erschöpfende Darstellung der jeweiligen individuellen Situation und die darauf aufbauende Thera-
pieentscheidung sind aber entscheidend für die Prognose des Patienten, da der erste, gut geplante
„Schuss“ entscheidend für den weiteren Verlauf ist und nicht mehr korrigiert werden kann.
In dieser Arbeit werden neue Konzepte zur Verbesserung des Informationsmanagements im Be-
reich der Kopf-Hals-Tumorbehandlung entwickelt, als prototypische Software implementiert und
im klinischen Alltag in verschiedenen Studien wissenschaftlich evaluiert. Die Erlangung eines tief-
greifenden Verständnisses über die klinischen Abläufe sowie über beteiligte Informationssysteme
und Datenflüsse stellte den ersten Teil der Arbeit dar. Aufbauend auf den Erkenntnissen wurde ein
klinisches Informationssystem oncoflow entwickelt. Oncoflow importiert vollautomatisch relevante
Patientendaten von verschiedenen klinischen Informationssystemen, restrukturiert die Daten und
unterstützt Ärzte und Chirurgen im gesamten Therapieprozess. Das System wurde anschließend in
unterschiedlichen Studien evaluiert und der klinische Nutzen in Bezug auf effizientere Arbeitsabläu-
fe und eine verbesserte Informationsqualität gezeigt. Im folgenden Teil der Arbeit wurden Machine
Learning Methoden genutzt um von Daten in der elektronischen Patientenakte auf den aktuellen
Prozessschritt im Therapieprozess zu schließen. Der letzte Teil der Arbeit zeigt Möglichkeiten zur
Erweiterung des Systems zur Nutzung in weiteren klinischen Fachdisziplinen auf.
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Chapter 1
Introduction
1.1 Motivation
Head and Neck Squamous Cell Carcinoma (HNSCC) is the fifth-leading cause of cancer incidence
in Germany with 16.500 patients in 2010 [1]. Head and neck cancer occurs in organs such as the
oral cavity, oro- and hypopharynx, the nasopharyngeal zone or in the larynx and is closely related
to a variety of risk factors which include amongst others nicotine or alcohol abusus, exposure to
chemicals, and also certain viruses such as the human papillomavirus [2]. The tumor therapy has a
profound impact on the patient’s quality of life due to partly severe surgical interventions such as
the removal of the larynx in combination with radiation therapy. Additionally, the Eurocare-4 and
Eurocare-5 cancer studies analyzed the survival rates of tumor patients from all over the European
Union between 1995 and 2007 and present sobering result. The relative 5 year survival rate for
adult patients with HNSCC is at 42% [3, 4].
The detection and the treatment of HNSCC is a complex task that requires a high degree of inter-
disciplinary cooperation between different specialized medical disciplines [5]. Involved disciplines
are head and neck surgery, maxillofacial surgery, radiation oncology, oncology, pathology, radiol-
ogy and nuclear medicine. However, a crucial prerequisite to find the best possible therapy for the
patient and to increase its outcome is that all physicians and surgeons have a common understand-
ing of the patient case. Therefore, patient-specific information such as risk factors, blood-count,
examination results of biopsy samples or medical images have to be available and conveniently
accessible for the clinical staff.
Unfortunately, the information that is currently acquired lacks standardized contents, a structured
documentation, and is distributed and encapsulated across different clinical information systems [6].
Hereby, the Hospital Information System (HIS) is the leading information system for text-based
information and medical images originating from e.g. Computer Tomography (CT) or Magnetic
Resonance Imaging (MRI) scans are stored in the Picture Archiving and Communication System
(PACS). Also further department-internal information systems are used in daily clinical routine for
special-purpose tasks [7]. These proprietary systems are commercial or originate from scientific
1
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projects and are slightly or not integrated into the existing clinical IT-infrastructure.
This situation leads to several implications in daily clinical routine. Existing information is not
instantly usable in electronic form, e.g. the automated creation of clinical documents such as physi-
cian letters or quality management reports is not possible. Currently, the physician has to login into
different information systems, browse paper forms and manually aggregate relevant information
in a time-consuming and error-prone copy & paste process. Due to proprietary database systems,
users also don’t have the possibility to directly access the database and perform a bulk export of
patient data to transfer important information from the HIS to statistic tools for statistical evalu-
ations. The heterogeneous information base serves at the moment as basis for therapy decisions,
quality management and clinical studies but in fact these tasks require structured information within
a centralized database [8, 9].
Especially in tumor boards where physicians from different medical disciplines meet to find
together the best possible therapy for the patient a common understanding or common mental
model based on structured information would be beneficial [10]. However, the management of
these meetings is not well integrated into the existing IT infrastructure [11]. Furthermore, existing
patient-specific information is not processed adequately to improve a common understanding of
the actual case and the environment where tumor board meetings take place is not designed as a
collaborative platform for knowledge-sharing and a productive decision-making process.
The presented work aims to develop basic requirements for the information management in
the field of oncological head and neck surgery and to transfer this theoretical knowledge into a
prototypical web-based clinical information system oncoflow. The work focused on the following
topics:
1. Standardized and structured information acquisition
2. Integration of patient information
3. Clinical workflow support and automation
4. Tumor board support
5. Quality management and clinical certification
The oncoflow system has been deployed at a clinical site and the development was attended by
clinical studies. The goal of these studies was to evaluate the oncoflow system in daily clinical
routine with regard to the improvement of information acquisition, information quality and work-
flow support compared to the information systems that were used so far. The trade-off between
the involved resources for improving information quality (e.g. an increased consultation time) and
the noticeable advantages in daily clinical routine are weight by the clinicians and decide on the
acceptance or refusal of the new oncoflow information system [12].
In the scope of this doctoral thesis the clinical workflow was analyzed and corresponding work-
flow assistance systems were realized for the clinical anamnesis, panendoscopy, tumor board and
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follow-up process steps. The therapy process step that includes radiotherapy, chemotherapy and
surgical intervention was not considered in this work and is subject of further research.
1.2 Clinical setting and system context
The clinic of Otolaryngology, head and neck surgery at the University Medical Center Leipzig is an
independent clinic with ambulance, ward, phoniatry and operation rooms. About 200 patients per
year with primary diagnosis head and neck cancer are treated with full in-house services for cancer
therapy from pre-op consultation to post-op evaluation, check-up and therapy. Each patient passes
through a treatment process consisting of a diagnostic, a therapy and a follow-up phase with a total
time of at least 5 years. This work focuses on the treatment process, clinical information systems
used in each process step and the overall integration into daily clinical routine (see Figure 1.1).
Consultation Panendoscopy Tumor Board 
Therapy Tumor Board Follow-up 
GTDS 
DTTM 
CREDOS 
HIS 
iSoft HIS 
GTDS 
CREDOS 
HIS 
GTDS 
CREDOS HIS 
GTDS 
CREDOS 
HIS 
Figure 1.1 – Treatment process in head and neck surgery with major clinical information sys-
tems1supporting daily clinical routine. A panendoscopy is a routine comprehensive endo-
scopic examination of the upper aerodigestive tract in total anesthesia. The figure illustrates
the heterogeneity of supporting information systems
The General Practitioner (GP) is frequently the first contact person when patients develop clinical
symptoms such as difficulties in swallowing which do not disappear after a short time period. If
the disease can not be cured within an adequate time frame or if the GP immediately suspects
cancer the patient is referred to a specialized clinic or to a university hospital. In the depicted
1The leading information system is the Hospital Information System (HIS). Supporting systems during therapy are
Picture Archiving and Communication System (PACS), Dornheim Tumor Therapy Manager (DTTM), iSoft labora-
tory documentation and the Treatment Planning System (TPS) for radiation therapy. Cancer Retrieval Evaluation
and DOcumentation System (CREDOS) and Giessener Tumordokumentationssystem (GTDS) support the tumor
documentation
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example case the patient may be referred to specialists from head and neck surgery. Subsequently,
the patient arrives in the department of head and neck surgery where a patient record in the HIS is
created. During a first consultation the actual status of the patient is documented. The consultation
consists of an anamnesis where the physician asks questions concerning current medical conditions,
past interventions and way of life and a clinical examination where the physician examines ears,
nose, oropharynx and larynx and performs a palpation and an ultrasound examination of neck
lymph nodes. When a tumor is assumed morphological as well as functional medical imaging
such as CT, MRI or Positron Emission Tomography (PET) is also performed and a panendoscopy,
an examination for better contouring of the tumor extension under total anesthesia, is performed.
During panendoscopy samples of potential tumor tissue are taken and sent to pathology for a
histopathological examination. Subsequently, the DTTM supports the surgeon in reporting the
biopsy locations, creating a clinical TNM Classification of Malignant Tumors (TNM) classification
as well as a 3d tumor reconstruction [13, 14, 7]. Based on a positive histopathological result the
patient is scheduled for the next tumor board. The head and neck tumor board in Leipzig takes place
every Thursday where about 12 to 15 patients are discussed. Tumor board invitations and result
protocols are created with MS-Word templates and sent via email to all participants. The complete
scheduling process for one patient is very time-consuming for the attending physician. Information
gathering from HIS and paper-based records and the creation of invitation and protocol take up to
30 minutes. After the first tumor board took place data export to additional information systems
such as the GTDS and CREDOS are mandatory. Necessary information is manually reentered
from HIS, the laboratory software iSoft and paper records by tumor documentation assistants for
usage as tumor documentation and retrospective clinical studies. The therapy phase consists of a
combination of chemotherapy, radiotherapy and surgical intervention depending on the decision
in the tumor board. After each therapy, the patient is scheduled once more for the tumor board to
discuss the therapy outcome, further therapies or the release of the patient into follow-up. During
the follow-up phase the patient is scheduled for regularly meetings over the next five years where a
clinical examination is performed and the current patient status is documented into the paper-based
patient record and afterwards in the HIS.
1.3 Scope of the work
The concepts and information systems that are presented in this doctoral thesis aim to improve the
oncological treatment process in terms of information integration, structured information acquisi-
tion, information quality, clinical workflow support and automation as well as quality management.
The information system oncoflow and the Treatment Planning Unit (TPU) have been developed in
close cooperation with physicians and surgeons from the department for head and neck surgery at
the University Medical Center Leipzig and are tailored to the specific requirements in this medi-
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cal discipline. However, the presented concepts are generally accepted for cancer treatment in all
medical disciplines and are not solely tailored to head and neck cancer treatment. The informa-
tion systems have been developed in a modular and easily extensible fashion with a facilitated
modification, integration and application in other clinical disciplines in mind.
This work focuses on clinical workflows, information models and assistance functions to relieve
clinical personnel from time-consuming and error-prone tasks. Additional information systems
which are considered throughout this thesis only serve as information sources or information sinks.
These systems such as SAP i.s.h.med or the DTTM are important with regard to information
exchange between them and oncoflow and their role in the oncological treatment process. The
functions which these systems provide are not in the scope of this work and thus, are not analyzed
or described in detail.
1.4 Goals of the work
The major goals of this thesis are depicted in detail in the following subsections and are briefly
illustrated in Figure 1.2. Gaining a deep understanding of the clinical workflow for tumor patient
treatment in head and neck surgery was the first goal. Therefore, it was necessary to understand
the process steps, actors and their roles, and the information flows as well as to identify clinical
information systems that are used.
The second goal was the development of a web-based information system oncoflow that auto-
matically imports patient-specific information, provides convenient and user-friendly access to this
information and allows a structured documentation of treatment results.
The information system was then deployed at a clinical site and used by the physicians and
surgeons in daily clinical routine. Hence, the database contains a growing amount of structured
information that is the basis for workflow support, process automatization and quality assurance.
Thus, the third and fourth goal use the information base for the development of intelligent workflow
assistance systems and efficient tumor board support.
The improved assistance functions were evaluated in daily clinical routine in goal number five.
The recognition of clinical workflows by using machine learning approaches is goal number six.
Finally, concepts for the generalization of the aforementioned methods for a usage across different
clinical disciplines have been developed.
1.4.1 Information management in oncology
Goal 1 A deep understanding of underlying clinical workflows, involved physicians and surgeons
as well as necessary patient-specific information and the information systems or paper records
where this information is stored is crucial. Hence, a detailed workflow analysis resulting in a
precise documentation of the clinical setting was the first goal.
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Figure 1.2 – Major goals of this doctoral thesis
Goal 2 The access to relevant patient-specific information in the previously identified information
systems and an automatic integration into one central database is the prerequisite for clinical
workflow assistance and the second goal. For this purpose an appropriate information system with a
central database was developed and electronic communication interfaces to the information sources
were established.
1.4.2 Clinical workflow support
Goal 3 Based on centralized available information the development of assistance systems for
physicians and surgeons in daily clinical routine are the third goal. Therefore, a web-based informa-
tion system oncoflow was implemented which aggregates and structures existing patient-specific
information and provides convenient access and workflow support functions for physicians and
surgeons.
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Goal 4 The fourth goal was the improvement of the decision-making process in the tumor board.
Therefore, existing conditions in the tumor board meeting room were analyzed in detail and an
appropriate room design as well as useful assistance functions to support the decision-making
process were implemented.
Goal 5 The next goal was the evaluation of the implemented workflow assistance functions
in daily clinical routine. Therefore, the oncoflow system was deployed in the clinical computer
network at the department of head and neck surgery and used in daily clinical routine. Within
different quantitative and qualitative evaluation studies the benefit of oncoflow compared to the
existing clinical information systems was evaluated.
1.4.3 Clinical workflow recognition
Goal 6 In order to provide appropriate clinical workflow assistance, quality management, and
foster clinical certifications patient-specific information has to be structured according to the actual
treatment phase and enriched with meta-information. Hence, the sixth goal was the development
of probabilistic models which allow the prediction of the patient’s current step in the treatment
process based on information available in the EPR.
1.4.4 Generalization and multidisciplinary usage
Goal 7 Finally, the concepts developed in this work and the information system oncoflow should
be generally accepted and not be tailored to a specific medical discipline. Thus, the last goal was
the enhancement of the system for a more generalized usage.
1.5 Thesis outline
This thesis is divided into eight chapters representing the scientific methods and evaluation results
in chronological order.
Chapter 1 presented in detail the motivation, the clinical context, the scope, the goals and the
outline of this work. In Chapter 2 a detailed overview on existing scientific research projects
and commercially available software products is given. The chapter is divided into four sections
covering the topics electronic patient records, tumor board support, workflow recognition and
distance measures for workflow evaluation.
Chapter 3 provides detailed information on the technical realization of the oncoflow clinical
information system. Within the oncoflow system all scientific methods which are developed in this
thesis were realized as prototypic implementation. Hence, oncoflow is the basis for all subsequent
chapters and clinical studies which were performed in this work. The first section of this chapter
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presents the oncoflow information model which is the basis for the backend database scheme. The
second section gives a brief overview on the system architecture of the web-based application.
In Chapter 4 all functionalities for supporting physicians, surgeons and clinical staff in daily
clinical routine which are already implemented in oncoflow are described in detail. The assistance
functions are described in the same order as they appear in the actual treatment process starting
from the first consultation until the final data aggregation and data export for clinical studies. The
scientific evaluation of these assistance functions in daily clinical routine is presented in Chapter 6.
A concept of a sophisticated multimedia tumor board, the TPU, is presented in Chapter 5. The
TPU provides workflow assistance for the management of tumor boards including the scheduling
of patients and invitation and result mailings. Furthermore, the TPU consists of a wide variety
of technical equipment that is installed in the team meeting room at the clinical site and helps to
improve the decision-making process during tumor board conduction.
The oncoflow system has been deployed at a clinical site and is still used in daily clinical routine.
Different clinical studies were conducted in a tight cooperation with physicians and surgeons to
evaluate the advantages of the new information system. The results of these studies are presented
in detail in Chapter 6.
The information management in clinical information systems is rarely tailored to the needs of
physicians and surgeons. Thus, in Chapter 7 a completely new approach for clustering patient-
specific information is presented. Hidden Markov models are used to enrich information with
meta-data about the therapy process step from which this information originates. The developed
algorithms are evaluated in a leave-one-out cross-validation study.
In Chapter 8 a concept for extending the methods which were originally developed for head
and neck surgery to a broader area of application is presented. This concept aims to generalize the
existing EPR in oncoflow to enable the usage of the system in a broader field of application. As an
example an approach for the integration of radiation therapy planning into oncoflow is discussed.
Finally, in Chapter 9 the contents of this thesis are briefly summarized and the degree of goal
achievement from Chapter 1 are presented. Furthermore, experiences gained from the development
of oncoflow and the usage of the system in daily clinical routine are discussed in Section 9.3.
Additionally, future work items are presented and final conclusions are made.
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Related work
2.1 Introduction
This chapter gives a brief introduction to existing research projects and commercially available
software products related to the topics of this thesis.
Various kinds of existing EHRs and approaches for EHR design presented in Section 2.2 are a
considerable information base for the development of clinical information systems. Most of the
existing systems focus on very specific clinical disciplines or surgical intervention types and are
not suitable for the usage in oncological head and neck surgery. However, information which is
important for oncology and acquired in CREDOS and GTDS is available in oncoflow in order to
support the clinical workflow, studies and certifications. The usage of those systems itself is not
possible due to limitations accessing the information from the databases, because these systems are
commercial products.
The support of tumor boards is covered in Section 2.3. The solutions presented in this section
partly provide important assistance features such as the scheduling of patients for tumor boards,
web-based presentation or teleconferencing. The TPU in combination with oncoflow implements
much of the presented functions within one integrated system but provides many additional features
especially during tumor board conduction as depicted in Chapter 5.
The recognition of workflows in the field of medicine is mostly applied to specific surgical inter-
ventions as depicted in Section 2.4. Theoretical approaches are mostly based on HMMs or Bayesian
networks and were inspiring for the workflow recognition presented in Chapter 7. However, the
approach presented in this work differs significantly from the related work projects and has not
been investigated before to the best of our knowledge.
Section 2.5 presents research projects focusing on the comparison of documentation workflows in
the field of medicine. The conclusion of all presented papers is that precise and complete documen-
tation of medical information is crucial for the improvement of therapy outcome and the conduction
of clinical studies. In order to compare clinical workflows Schumann et al. investigated in finding
the most appropriate algorithm for comparing clinical workflows. Hence, the resulting Levenshtein
9
2.2. ELECTRONIC HEALTH RECORDS
algorithm was applied to results from a clinical study presented in Section 6.6 in order to compare
workflows for the documentation of the first consultation in head and neck tumor therapy.
Finally, one can conclude that many research projects and available software products already
address aspects that are also in the focus of this thesis. However, a combination of these aspects that
are integrated into one clinical information system which supports efficiently the treatment process
of tumor patients and is well integrated in daily clinical routine is not available at the moment. Thus,
the oncoflow system and the concepts presented in this thesis provide a basis for the development
of future EPRs and clinical workflow assistance systems.
2.2 Electronic health records
2.2.1 Requirements of EHRs
Yu et al. investigated in requirements for EHRs especially for oncology [15]. The authors state
that EHRs are not a digital copy of a paper-based medical record but provide flexibility in data
presentation and the possibility to perform data mining, data analysis and generate new knowledge.
EHRs should actively assist in the delivery of more efficient and higher quality health care.
In 2006 the US federal government provided an initial funding for the Certification Commission
for Health Information Technology (CCHIT) to certify EHRs for functionality, interoperability,
privacy and security. Unfortunately, those requirements do not meet the specific needs for EHRs in
oncology. Thus, in 2009 an overview document has been released which describes specific require-
ments for oncological EHRs [16]. The whitepaper describes functional requirements and clinical
data elements. A cancer data standards repository (caDSR) was established that contains common
definitions for structured data elements to facilitate information exchange between different clinics
and information systems.
Functional requirements cover all kinds of patient-specific information that is relevant in the
scope of tumor documentation. The complete list of requirements is available in [16]. In Table 2.1
a summary of the most important functional requirements is shown, which serves as reference for
an ideal oncological EPR.
2.2.2 Nationwide solutions
The GTDS provides a German large regional tumor database primarily for follow-up documentation
funded by the German Federal Ministry of Health [17]. The goal of GTDS is to facilitate the
documentation of the course of the disease including secondary diseases and long-term side-effects
with respect to the actual disease and primary therapy. The documentation is performed by clinical
staff as soon as a patient receives a histological confirmed tumor classification. The development
of GTDS started in 1991 and is until now connected to 40 cancer centers in Germany so that during
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Table 2.1 – Functional requirements for EHRs in oncology (Source: [16])
Category Requirements
Cancer Treatment Plan • Demographic information
• Diagnosis
• Tumor staging
• Pathology findings
• Co-morbid conditions
• Prior treatment
• Current treatment plan
• Clinical trial protocol number
Cancer Treatment Summary • Information from treatment plan
• Delivered chemotherapy
• Delivered biotherapy
• Major experienced toxicities
• Palliative care and hospice plans
• Follow-up care provider
• Tasks & timelines for disease recurrence monitoring
• Long-term adverse effects form treatment
Oncology-specific Documentation • Tumor staging
• Radiation reports
• Chemotherapy records
• Pathology reports
• Pain assessment
• Patient consent forms
• Eligibility for clinical trials
• Clinical trial summaries
• Patient education materials
• End-of-life documents
Oncology-specific Functionality • Chemotherapy and drug management
• Dose calculations based on weight and lab results
• Scheduling functions e.g. visits, infusions, etc.
• Support clinical trials and research
• Integration of bar-coding or RFID technology
• Generation of quality metrics and other reports
• Patient portal with Personal Health Record (PHR)
the past 24 years a huge amount of tumor data was collected. On the other hand, the age of the
system, a lacking integration into the clinical workflow and only few assistance functions make the
system less appealing for the usage in daily clinical routine.
The university medical center Ulm developed an extensive and certified cancer documentation
tool CREDOS based on the SAP infrastructure [18]. The CREDOS system provides a standardized
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tumor documentation, the import of little patient master data from the HIS, an automatic export to
the GTDS as well as basic functions for supporting the certification to a cancer center. However, the
system is lacking meaningful data import capabilities from the HIS which leads to time-consuming
copy & paste work for the documentation assistants. Additionally, information entered in GTDS or
CREDOS is not verified so that information quality is dependent on the work of the documentation
assistant and can not be assured.
2.2.3 Monocentric or multicentric solutions
Wu et al. developed a comprehensive database management system for the organization and eval-
uation of mammography data sets [19]. The system is designed for the collection of consecutive
mammography reports to develop reliable decision support systems and the implementation of accu-
rate medical audits. Therefore, standardized, well-documented and transparent methods according
to Brest Imaging Reporting and Data System (BI-RADS) and the Mammography Quality Stan-
dards Act (MQSA) are used to ensure data accuracy and facilitate data sharing and communication.
Between 2006 and 2011 nearly 30,000 patients were accumulated in the database and 117 distinct
pathologic diagnoses were cataloged for a pathology lexicon.
The university hospital in Dresden, Germany, developed an oncology information system MA-
DOS4 for longitudinal basic tumor documentation [20]. The system implements six tumor notifi-
cation forms for clinical diagnostics, tumor board, therapy, follow-up, recurrence and completion.
The system contains additional documentation forms for breast, prostate and colorectal cancer.
Histopathological information which is necessary for tumor documentation can be directly entered
in the system or automatically imported from different pathological information systems via Health
Level 7 (HL7) interface.
Segagni et al. developed an integrated infrastructure, the ONCO-i2b2 platform, for the integration
of clinical and research data to support translational research in oncology [21]. The platform inte-
grates data originating from different information sources, stores them into a data warehouse and
allows facts to be hierarchically structured as ontologies. The system actually manages data of more
than 6500 breast cancer patients which were collected between 2001 and 2011 at the Fondazione
Salvatore Maugeri hospital in Pavia, Italy.
Holzner et al. developed a comprehensive system for Patient Reported Outcome (PRO) docu-
mentation [22]. The system is based on tablet computers where patients can enter treatment-related
information themselves. Thus, the routine collection of patient data with a reduced amount of hu-
man resources is possible in daily clinical routine. The information that is captured is e.g. related to
quality of life, fatigue, depression, medication side-effects or disease symptoms. These are impor-
tant parameters for medical research or daily clinical practice. The software allows to administer
questionnaires and present the results. The software is widely used in various institutions in Austria,
Switzerland, and the UK. About 5000 patients participated in the usage of the system.
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Weiner et al. developed an EPR system which automatically notifies physicians about eligible
patients for prospective clinical studies in realtime [23]. A clinical trial study at the Children’s
Hospital Boston compared the notification about eligible patients before and after the introduction
of the new system. During an eleven month time-frame without the system the investigator was
notified in 56% out of 61 patients, within a study time-frame of ten months with the notification
system the investigator was informed in 84% out of 49 patients.
2.2.4 Scientific research projects
The Surgical Data Recorder developed by Rockstroh et al. aims at the structured documentation
of intra-operative device information in a central database [24]. This approach targets the full-
automatic collection of information generated by clinical devices which are available on the OR
bus; hence, basically low-level information such as vital signs, device parameters or video streams
are recorded. This information may be useful for the oncoflow system after a postprocessing phase
so that only high-level information about the course of the intervention is available.
Documet et al., Le et al. and Deshpande et al. developed electronic patient record systems for
minimally invasive spinal surgery and prostate cancer treatment [25, 26]. These systems are tailored
to specific intervention types and provide automatic vital sign documentation, video documenta-
tion of endoscopic video devices as well as support for pre-operative planning and post-operative
activities.
Zhang et al. developed a hierarchical radial approach for the visualization of patient information
[27]. This approach uses a tree data structure for the storage of the main diseases as parent nodes and
child nodes for more detailed information instead of using a timeline for information visualization.
The implications of German law on the implementation of cross-institutional health records and
the application at the Thoraxklinik Heidelberg are presented from van der Haak et al. [28]. Safran
et al. present a whitepaper of a national framework for the secondary use of health data as well as a
summary of the experiences with online medical records during one decade [29, 30].
The role and importance of information systems in healthcare is the main research topic at the
Institute for Medical Informatics, Statistics and Epidemiology (IMISE) at the Universität Leipzig
[31]. Winter et al. provide detailed concepts of the implementation of health information systems
within a multi-tier architecture reaching from physical devices in the IT department until the mod-
eling of organizational processes. Besides technical realizations the work also focuses on the users
of these systems as well as the behavioral and societal changes originating from an increasing IT
support of all tasks in daily clinical routine.
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2.3 Tumor board support
Patkar et al. investigated in the effectiveness of tumor boards on improved therapy outcome and
suggested the usage of advanced clinical decision support systems to realize the full potential of
tumor boards [11]. The first part of this work focused on the evidence on the impact of tumor
boards. Therefore, scientific articles on the evidence of tumor boards have been reviewed. The
respective outcomes were categorized into nine categories like survival rate, quality of life or time to
intervention. The authors identified one randomized controlled trial study that shows no significant
differences between cases discussed in tumor boards and the control group. Eight observational
studies in different cancer domains reported improvements for tumor board patient cases. Only one
study focused on cost-effectiveness of multidisciplinary melanoma care at large academic medical
centers in the United States compared to traditional community-based treatment. Unfortunately,
Patkar et al. found that the study design of almost all articles was poor but the authors did not suggest
to interpret the absence of good-quality evidence as the evidence of ineffectiveness of tumor boards.
Finally, the authors felt confident that health information technology could assist in structural
and administrative aspects of tumor boards such as preparation, data collection, presentation and
consistent documentation of decisions.
Eisner et al. provide detailed insight into organisational and technological changes at the “Steier-
märkische Krankenanstaltengesellschaft m.b.H.” in order to implement integrated tumor board
management into the local HIS SAP i.s.h.med [32]. Prior to the integration relevant patient-specific
information was transferred to the tumor board moderator via phone, fax or email. Afterwards,
the moderator created tumor board invitations which were then sent to all participants via email.
During the meeting the moderator noted the results and created meeting protocols which were
sent few days later as email to the board participants. Additionally, the moderator transferred the
results into the HIS. The complex process has been improved significantly by integrating the entire
registration and documentation process into the HIS. Physicians and surgeons are now able to
schedule their patients themselves at every hospital computer which has access to the HIS. The
tumor board registration is then automatically completed with patient demographic information as
well as existing tumor documentation. Tumor board invitations can then be immediately sent to all
participants. Therapy decisions are complemented after the board meeting, so that also the tumor
board protocols are instantly available in the HIS, centrally available for the attending physicians
and surgeons and ready for the distribution across the board participants.
Bumm et al. and Siess et al. established a comprehensive IT infrastructure for tumor board man-
agement, results documentation and clinical study management at the university hospital “Klinikum
rechts der Isar” in Munich [33, 34]. Firstly, the entire tumor board management process has been
analyzed and requirements for an appropriate IT infrastructure have been derived. Afterwards, a
centralized, web-based information system Onkofile was developed. The system has been installed
in the local clinic network and provides tumor board management, patient registration and par-
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ticipant invitation. Scheduled patient cases can be enriched with textual information as well as
medical images. The system also provides an instant results documentation during the tumor board
meetings and an automatic mailing of tumor board invitations and results. Furthermore, a clinical
study management provides important parameters of ongoing studies during the tumor boards.
Li et al. developed a web-based teleconference system to support distributed tumor conferences
at multiple locations [35]. The system provides a web-based tumor board management with a
centralized availability of patient-specific information such as Word documents or Powerpoint pre-
sentations. During the video conferences the moderator is responsible for presenting the available
information to the participants. The tumor conference participants are able to edit presented infor-
mation in real-time which enriches the interaction and discussion possibilities between the remote
locations.
Summarizing the shortcomings and goals of the shown literature leads to the following require-
ments on tumor boards:
• Automatic creation of tumor board invitations and protocols
• Automatic import of as much patient-specific information as possible for invitation and
protocol creation
• Ensuring the consistent collection of crucial data such as disease staging and outcomes
• Consistent online documentation of tumor board decision and consent
• Ensuring that tumor board recommendations are followed in the practice
• Ensuring active patient participation
• Improving information exchange and regular communication flow between team members
• Establishing robust mechanisms for prospective assessment of tumor board performance
• Ensuring adherence with standards including evidence-based guidelines
• Establishing reliable interfaces with primary care to ensure continuity of care
• Achieving right balance of educational and care delivery objectives of this forum
• Allow patients the ability to fully explore all their available therapy options
• Eligibility of patients for recruitment into ongoing trials could also be screened in real time
during the board
• Access for all participating physicians on patient data, tumor board invitations and protocols
Further requirements for cancer center certification postulated by the Deutsche Krebsgesellschaft
(DKG) are discussed in Section 5.2.
2.4 Model-based workflow recognition
Knowledge of workflow information from surgical interventions and from perioperative processes
is important for the development of intelligent clinical workflow assistance systems. Therefore,
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statistical models such as HMMs [36] are appropriate for the recognition of workflow steps and are
commonly used in the medical field.
The course of a surgical intervention can be represented as a sequence of 5-tuples, the individual
Surgical Process Models (iSPMs), which contain process step information such as activity, actor,
surgical instrument, target structure and time [37]. Subsequently, multiple iSPMs can be merged
into a generalized Surgical Process Model (gSPM) [38]. A gSPM represents an averaged course of
the corresponding intervention type. Based on the aforementioned theoretical basis, Schumann et al.
investigated mathematical approaches for comparing iSPMs and gSPMs and assessing the quality of
surgical processes [39]. Franke et al. developed a representation of surgical interventions based on
Markov theory [40, 41, 42]. Based on the process knowledge that can be acquired from gSPMs, the
surgical intervention can be partitioned into different phases. Subsequently, the gSPM can be used in
combination with Markov theory to predict the actual high-level phase of an ongoing intervention
with the help of low-level tasks such as sensor information. Based on these models, intelligent
workflow assistance systems, such as systems that present surgical process information in the
operating room, can be developed. This method has already been applied to surgical interventions
in eye, neuro and ENT surgeries.
The following research studies investigated intraoperative workflow recognition during laparo-
scopic cholecystectomies and used HMMs for predicting surgical steps based on Operating Room
(OR) sensor information. Padoy et al. used the process information to predict the remaining inter-
vention time. The HMM in this project was developed from 12 recorded surgical interventions that
consisted of 14 surgical phases. This model yielded a high prediction error (> 14 min) at the begin-
ning of the intervention, but the error rate decreased significantly at the end (≈ 1 min) [43]. Blum
et al. developed a HMM from 11 laparoscopic interventions that consisted of 14 process phases for
the recognition of surgical phases during cholecystectomy interventions [44]. The evaluation of this
model with a leave-one-out cross validation yielded a positive phase detection rate of 93%. Bouarfa
et al. developed a framework to clean noisy sensor information with a Bayesian network approach
to infer the correct low-level task [45]. Subsequently, a HMM was used to infer the corresponding
surgical process steps based on the corrected low-level tasks with a prediction accuracy of up to
90%.
Modeling clinical workflows other than the OR is an emerging field of research for describing
and optimizing clinical pathways. Huang et al. used dynamic programming approaches to summa-
rize a clinical pathway from clinical event logs [46]. Medical behaviors in real-world event logs
are very diverse and heterogeneous, but the authors demonstrated the applicability of the presented
approach for creating condensed clinical pathway summaries in polynomial time. Subsequently,
Huang et al. investigated the use of process mining techniques to extract explicit clinical pathway
patterns from medical behaviors recorded in clinical workflow logs [47]. This research group fo-
cused on specific diseases, e. g. bronchial lung cancer, colon cancer, gastric cancer, breast cancer
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and cerebral infarction. Based on classical sequence pattern mining algorithms, the authors de-
veloped an algorithm tailored to the specific scenario (SCP-Miner) and performed an evaluation
against existing algorithms, such as CloSpan and BIDE. The results of the study demonstrated
that the proposed approach provides better outcomes in terms of processing time, scalability and
generated clinical pathway patterns. A later work of Huang et al. focused on improving the dis-
covery of clinical pathway patterns from event logs through the use of probabilistic topic models
[48]. The authors used a clinical event log from the cardiology department of the Chinese PLA
General Hospital and successfully discovered the underlying clinical pathway patterns using the
aforementioned method. The clinical pathway analysis can also be complemented by measuring
the similarities between patient traces. Huang et al. employed latent Dirichlet allocation (LDA)
to measure similarities between pairwise patient traces [49]. To evaluate the performance of the
proposed approach, comparisons with the edit-distance-based similarity measure and a classical
simple term vector-based method were performed. The precision of the LDA approach was 19%
higher than those of the edit-distance and vector-based outcomes.
2.5 Distance measures for workflow evaluation
The improvement of clinical documentation as well as information quality in EPRs is already
addressed in various research projects. Davis et al. developed a template within the EPR that
improves significantly the documentation of asthma severity and the appropriate treatment [50].
Bordowitz et al. state that physicians underdocument and undertreat obesity and implemented an
EPR that automatically calculates the body mass index and supports obesity documentation [51].
The documentation quality and also the treatment of obese patients have been improved significantly.
Menke et al. implemented a computerized clinical documentation system in a pediatric intensive
care unit resulting in an improved completeness of documentation, better accessibility and accuracy
of information and no change in time spent for patient care by clinical staff [52]. An appropriate
IT infrastructure is especially important in tumor documentation to provide physicians useful
information, evaluate standards of care and get an impression about the effectiveness in cancer
care [53]. Furthermore, the certification as comprehensive cancer center is important with regard to
legal regulations and financial means [34]. Therefore, a centralized EPR and supporting tools for
tumor therapy and cancer center certification have been developed at Innovation Center Computer
Assisted Surgery (ICCAS) aiming at targeting the previously mentioned drawbacks [54, 55, 56].
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Chapter 3
Information integration
3.1 The oncoflow information model
As a first step towards an improved information management an extensible, flexible and hierarchical
information model has been developed. In a close cooperation with clinical partners paper-based
records and clinical information systems involved in the oncological treatment process have been
analyzed. Afterwards, important information entities were identified and grouped into different
classes whereby each class represents a step in the clinical workflow (see Figure 3.1). Commonly
accepted standards such as the Union Internationale Contre le Cancer (UICC) were used as theo-
retical basis during the design of the information model [57, 58]. The information model allows an
instantiation of a temporal view of the patient history through a time stamped acquisition of diag-
nosis and therapy steps as well as an instantiation of a causal representation of stored information
based on the logical sequence of activities in the care process. Details of the most important entities
that can be directly mapped to process steps in the treatment process are listed in Table 3.1.
In the second step the information model has been converted into a relational database. This
database is the heart of the oncoflow system and contains all available patient information in a
structured manner. Furthermore, communication interfaces to relevant clinical information systems
such as SAP i.s.h.med and the DTTM have been realized to exchange data electronically and relief
the clinical staff from manually reentering necessary information into the central database (see
Figure 3.3).
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Figure 3.1 – Detailed information model depicting all information entities which are relevant in clinical
diagnostics, tumor board, therapy, and after care
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Table 3.1 – Detailed description of all information entities used in the oncoflow information model
Information class Information entities Primary data
source
Patient Name, Address, Date of birth, Referring physician HIS
Circumstances of death Family
Anamnesis Nicotine, Alcohol, Risk factors, Family anamnesis, Profession,
Medicaments
Anamnesis
Karnofsky index, Pain, Teeth status Examination
Diagnosis Case number, Date, ICD10 code, Description HIS
Procedure Case number, Date, ICPM code, Description HIS
Panendoscopy Endoscopy images, Biopsy location, clinical TNM DTTM
Histology Localization, Grading, pathological TNM, Histopathological
assessment
Histological
report
Radiology Evaluation report of radiological images Radiological
report
Intervention Personnel (Surgeon, Assistants, Staff), Detailed intervention
description, Neck-dissection levels
Intervention
report
Chemotherapy Drugs, Dose, Cycles Chemother-
apy
report
Radiotherapy Type, Target areas, Dose, Mucositis Radiotherapy
report
Follow-up Date, Complications, Recidivisms HIS
Laboratory results Blood count iSoft
Tumor board Type, Time, Location, Participants, Patients oncoflow
Attended participants, Therapy decision TPU
User Name, Group, Specialty, Mail address oncoflow
3.2 System architecture
The oncoflow framework is designed as a modular system to support the extension with new func-
tionalities and an easy integration with multiple external systems such as clinical information
systems, databases or workflow management systems. The core framework is built as a three-tier-
architecture according to the Model View Controller (MVC) design pattern (see Figure 3.2) [59].
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Presentation Layer 
Patient Data 
Management 
Tumor 
Board 
Support 
Clinical 
Workflow 
Support 
Scientific 
Evaluation 
& Export 
Application Layer 
Query API for Application Layer 
Extract, Transform, Load (ETL) 
Data Access 
Components 
MySQL 
Connector 
DTTM 
Connector 
HIS 
Connector 
Persistence Layer 
Figure 3.2 – The three-layer system architecture of oncoflow is built according to the MVC design pattern
3.2.1 Software components
Oncoflow was developed as a web-application based on the Vaadin application framework. Vaadin
provides convenient integration of pure Java Enterprise (JEE) development with Google Web
Toolkit (GWT) web technology. The software development takes place in Eclipse/Java and finally
the Vaadin GWT compiler creates a web-application which can be deployed on application servers
like Apache Tomcat. This approach has numerous advantages especially for software development
in a scientific environment. Firstly, Java is widely taught at universities, hence, the entry barrier
for researchers and student workers for maintaining the software is low. Furthermore, Vaadin re-
lieves the developer from Hypertext Markup Language (HTML), Java Script and other web-related
technologies and problems in favor of focusing on the specific programming problem. The en-
tire oncoflow application is solely implemented with free software products. The used software,
libraries and corresponding version numbers are depicted in detail in Table 3.2.
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Table 3.2 – Software components used during oncoflow implementation
Component Software Version
Operating system Debian Linux 6 Kernel 2.6.32
Database MySQL 5.1
Connector/J 5.1.31
Application Server Apache Tomcat 8.09
Webserver Lighttpd 1.4.28
Java Oracle Java JDK 1.8.0_05
Encryption OpenSSL 0.9.8
Web framework Vaadin 6.14
Charts Invient Charts 0.8.6
HighCharts 2.3.3
IDE Eclipse Kepler SR 2
3.2.2 Persistence Layer (Model)
The persistent storage in oncoflow is realized with a MySQL database system. The connection
between oncoflow and the database is established by the MySQL Connector/J library and the
Apache Tomcat web application server. In the chosen setup the Tomcat server uses the Connector/J
library, establishes connections to the database and maintains existing connections in a connection
pool. The connection pool provides high performance in highly concurrent environments and
performs the handling of idle connections so that the amount of open connections is dynamically
adjusted depending on the actual requirements.
Object Relational Mapping (ORM) provides a transparent layer between application layer and
database in oncoflow. Therefore, an ORM driver, the DatabaseObject, has been developed.
The driver recursively translates Java class variables and values into Structured Query Language
(SQL) statements and vice versa. A Java class that should be persisted in the database must inherit
from DatabaseObject. Database tables to the corresponding Java class can be automatically
created by using the method DatabaseObject.createDatabaseTable(). The Query
class provides an interface between the DatabaseObject and the Tomcat connection pool.
In order to persist a Java object into the database the Query interface provides the meth-
ods Query.insert(DatabaseObject) and Query.update(DatabaseObject). The
Query class then acquires a database connection from the connection pool. Afterwards, the meth-
ods DatabaseObject.generateInsertQuery() or
DatabaseObject.generateUpdateQuery() are used to create necessary SQL insert or
update statements. Finally, the SQL statements are executed.
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The Query class provides the method Query.select(Class<?>, String) to fetch in-
formation from the database. The first argument denotes the specific Java class which is inherited
from DatabaseObject. The second argument is optional and may contain a MySQL WHERE
clause to limit the results. Afterwards, the Query class executes the SQL statement and receives
a SQL result set. The result set is then passed to DatabaseObject which in turn provides the
method
getObjectFromResultSet(Class<?>, ResultSet) to create a corresponding Java ob-
ject. Each result object is finally stored in a table-like data structure, the BeanItemContainer,
which is the return value.
The following paragraphs depict in detail the oncoflow communication interfaces and the imple-
mented Extract (ETL) program logic. The interface to the HIS is unidirectional for security reasons.
The interface automatically exports patient master data, diagnoses, procedures, histopathological
results and radiological reports as comma-separated text files once a tumor diagnosis occurs for a
specific patient. These files are stored on a network share and moved into an archive folder after
successful import. The files contain the unique patient id, conduction date, International Statistical
Classification of Diseases and Related Health Problems (ICD) or the German Operationen- und
Prozedurenschlüssel (OPS) codes which are internationally denoted as ICPM as well as a textual
description of the specific codes. Histological and radiological reports include additional informa-
tion such as department, HIS-internal id codes and the detailed textual histological or radiological
statement.
The second interface to the DTTM uses Hypertext Transfer Protocol (HTTP) for the exchange
of patient master data, detailed tumor classification (TNM) and annotated endoscopic images. The
oncoflow 
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Anamnesis Documentation 
Risk Factors Allergies 
Comedication Profession 
Clinical Examination Results 
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Figure 3.3 – The oncoflow system provides electronic communication interfaces for automatic data im-
port as well as web-based documentation forms in order to assure structured information
acquisition
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DTTM is a local Windows application which can be opened from within the oncoflow patient record
with the current patient id as parameter. Afterwards, the DTTM establishes a HTTP connection to
oncoflow, transmits the patient id and oncoflow sends back the patient master data as Extensible
Markup Language (XML) file. After the physician finished the panendoscopy documentation results
are transmitted to oncoflow via a new HTTP connection. Textual results such as TNM classification
or tumor grading are transmitted as XML file and endoscopic images are stored in a zip archive.
Oncoflow then saves the information from the XML file, extracts the zip archive and adds the
tumor classification and endoscopic images to the specific EPR. The entire panendoscopy and
histopathological confirmation process is depicted in more detail in Section 4.3.
Information provided by the HIS is frequently unstructured continuous text. Hence, an exten-
sive processing of the data during import has been implemented providing restructuring of given
information and embedding the information into a semantic context inside the proposed informa-
tion model. Thus, patient-related information is available in a structured manner within the central
database and instantly usable for further electronic processing or complex search queries for retro-
spective clinical trial studies. Changes in reporting practice, e.g. changes in the meaning of ICD or
OPS codes are not yet implemented in the information model due to the unavailability of this infor-
mation in the data exported from the HIS. However, preserving the meaning of existing information
despite of changing reporting standards is an important feature in a future release of oncoflow.
3.2.3 Presentation Layer (View)
The presentation layer consists of a rich Internet application within the web browser. A schematic
representation of the User Interface (UI) is depicted in Figure 3.4. The UI has been designed
according to the modular application framework requirements. Hereby the header shows patient de-
mographic information such as patient name, gender and age as well as the username of the current
logged-in user and a logout button. Subsequently, the main navigation bar has been implemented
as a tab sheet where each application module is represented by one tab. Thus, each module is
easily accessible and the system can be simply enhanced with new software modules. The module
navigation bar is situated on the left side in the UI and contains module-specific contents. Even
though there are no constraints for the included navigation items the usage of this navigation bar
is mandatory for module developers. Finally, the module content area shows the actual module
content. There are no restrictions for developers so that this area may contain text, tables, graphics
or other content which can be realized with Java and the Vaadin application framework.
UI components such as buttons, text fields or tables are defined in Java (e. g. Button button
= new Button(“Login”)) and are afterwards rendered with GWT as HTML elements. Based
on the browser capabilities Asynchronous JavaScript and XML (AJAX) and the WebSocket protocol
are used to exchange information between web-browser and application server, listen to user events
such as button clicks or update UI elements where the content changed. A detailed diagram re-
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Figure 3.4 – Schematic representation of the oncoflow user interface
garding the client-side and server-side Vaadin architecture is provided on https://vaadin.com/book/-
/page/architecture.html.
The “Look and Feel” of the UI is determined by the used theme. The standard theme Runo which
is shipped with the Vaadin framework was mostly appropriate for the development of oncoflow in
terms of font size, color palette and usability. Adjustments of theme elements were rarely neces-
sary and could be achieved conveniently with Cascading Style Sheets (CSS) definitions in a user
generated styles.css file. An impression of the final user interface is given in Figure 3.5.
3.2.4 Application Layer (Controller)
The oncoflow application layer consists of a variety of different special-purpose modules and
is easily extensible by new functionalities. Each module consists of a module controller class
responsible for the module initialization and the connection to the oncoflow framework or other
modules if necessary. Each module gains access to the model via the previously described Query
class (see Section 3.2.2) and is responsible for the creation of a module navigation bar as well as
the module content (see Section 3.2.3).
Within the current development stage of oncoflow the system includes four modules for clinical
workflow assistance and one system administration module. The patient data management module
provides basic functionalities for oncoflow such as a patient list, search functions and the visual,
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Figure 3.5 – The oncoflow user interface
structured representation of the EPR. The second module provides extensive tumor board support
and is described in detail in Chapter 5. The clinical workflow support module covers several work-
flow assistance functionalities which are described in detail in Chapter 4. The scientific evaluation
and export module provides support for physicians and surgeons for selecting, exporting and visual
representation of information for retrospective clinical studies or quality management related tasks.
The module is depicted in detail in Section 4.7.
Finally, the administration module comprises user management, system settings and service
settings such as system variables or the activation or stop of data import services.
3.2.5 Data security
The oncoflow system deals with highly sensitive patient information. Hence, the information has
to be protected from illegal access and eavesdropping. In order to protect the information from
illegal access, user authentication is required. Each user must provide username and password on a
login screen before access is granted. Users are enforced to change their passwords after the first
login. The passwords itself are stored as hash value in the database, protecting the users privacy. A
group-based rights management was implemented which significantly facilitates the assignment of
access rights to multiple users simultaneously. The user can be assigned to different user groups
with varying permissions which are listed in detail in Table 3.3.
Information transmitted over Local Area Networks (LANs) is prone to eavesdropping or illegal
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Table 3.3 – Group-based rights management in oncoflow
Group Permissions
Full administrator The full administrator has access rights to patient information as well as
to all technical settings.
Clinical administrator The clinical administrator has access to all patient-specific information
including the right to delete patient records.
Technical administrator The technical administrator has access to all oncoflow settings such as
user management, password reset and the data import services.
Physician The physician has access to all patient-specific information and is able
to change existing information.
Assistant physician Assistant physicians can see all patient information, add new
information entities e. g. documenting an anamnesis, but are not
allowed to change existing information.
Manager Managers have no access to patient-specific information. This group is
only able to perform statistical evaluations.
access without appropriate security measures. The oncoflow application framework is completely
web-based, hence, information visible on the users screen has been entirely transmitted over inse-
cure network connections beforehand. Thus, security measures were put in place to protect sensitive
information during the transmission in the hospital network. The transport security has been es-
tablished with self-signed Secure Socket Layer (SSL) certificates which were created with the
OpenSSL library. We decided to use the Lighttpd Web server as the primary communication end-
point for the user in favor of Apache Tomcat itself. The reasons were that the implementation of
SSL encryption in Tomcat is rather complex but easily configurable in Lighttpd and that Lighttpd
hosts further services such as a web-based SQL administration tool or a bug tracking system. How-
ever, Lighttpd forces the entire communication to be encrypted with SSL encryption so that login
and patient-specific information is protected.
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Chapter 4
Workflow assistance in daily clinical
routine
4.1 Introduction
Physicians and surgeons follow the workflow which is described in detail in Section 1.2 in daily
clinical routine. Unfortunately, they need to cope with all previously mentioned drawbacks originat-
ing from distributed information systems. The oncoflow system aims to improve these shortcomings
by supporting the clinical staff during the complete patient treatment process. Therefore, oncoflow
orchestrates a multitude of assistance functions originally provided by different information sys-
tems within a clear web-based user interface to efficiently support the clinical staff. This chapter
describes all workflow assistance modules in detail which are implemented in oncoflow and which
are already in use in daily clinical routine at the clinical site. A clinical study in which the process
improvements were evaluated was conducted at the department of head and neck surgery. The study
results are presented in Chapter 6.
4.2 Standardized anamnesis documentation
The first consultation of tumor patients reveal important information about the patient’s current
medical status. Based on this information the physician makes a diagnosis and prepares the follow-
ing therapy. At the moment the results of anamnesis and clinical examination are documented as
continuous text in the HIS into the so-called ambulance card. Most physicians use word templates
containing relevant but slightly varying headlines for the structured documentation process. These
headlines are transferred with copy and paste into the ambulance card and used as reference for
the documentation process. However, important information e.g. about nicotine or alcohol abusus
are lost in the free-form text, thus, are hardly usable for retrospective analysis, clinical studies or
workflow assistance.
In order to find a standardized documentation of the first consultation we conducted several
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interviews with all physicians and surgeons from the local head and neck department that are
involved in tumor treatment. During these meetings the relevant questions to the patients, the order
in which they are posed and all supporting documents have been acquired. The first part of questions
covers the anamnesis process. During this phase the physician talks to the patient and documents
relevant information simultaneously. Questions are related to the current problem, medication,
profession, family anamnesis and risk factors such as nicotine or alcohol. Subsequently the clinical
examination is performed with a detailed examination of ears, nose, oral cavity, hypopharynx and
larynx as well as a palpation of the neck lymph nodes. Finally the results are documented in the
HIS.
A consolidated document which contains the standardized sequence of questions has been de-
veloped and finally verified by the participating physicians after the workflow analysis. Then the
agreed set of questions has been implemented in oncoflow as a web-based form (see Figure 4.1).
The form consists of free text fields for unstructured information as well as predefined checkboxes
and dropdown fields for important therapy-related information such as nicotine consumption, pain
or Karnofsky index. Some values especially for clinical examination questions are completed be-
forehand with standard values in order to relieve physicians from additional documentation effort.
Form-based results documentation actually provides workflow support and improves information
quality (see Section 6.6). Physicians are guided through the consultation process in a standardized
manner and are relieved from using additional documents. Different text input fields and check
buttons improve the user experience during the documentation and provide structured information
storage at the same time. Hence, the information can be queried via SQL and is instantly available
for further usage. There are also fields for unforeseen but relevant information available where the
physician may add further notes that do not fit into existing categories. The EPR was also enriched
with patient photos. Patient photos are an important means during tumor board discussions to give
physicians which are not familiar with the patient an impression of its physical status. Especially
for radiotherapists the patient’s constitution is the basis for an optimal therapy planning.
A clinical study was performed to evaluate the presumed advantages of structured results docu-
mentation (see Chapter 6). The study focused on the overall satisfaction of the web-based system,
the time needed for results documentation compared to the current workflow and finally the infor-
mation density which should be improved with a structured documentation form.
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Figure 4.1 – Structured, web-based oncoflow anamnesis documentation form
4.3 Panendoscopy and histopathological confirmation
The panendoscopy is a diagnostic intervention under full anesthesia in order to perform a detailed
examination of oral cavity, hypopharynx, larynx, esophagus and trachea. A panendoscopy consists
of a combination of endoscopic examinations:
• Pharyngoscopy
• Microlaryngoscopy
• Tracheoscopy
• Bronchoscopy
• Esophagoscopy
• Epipharyngoskopy
Additionally, tissue samples of potential tumor tissue are taken during the intervention (see Figure
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4.2). Each biopsy sample is pinned on a piece of cork and numbered consecutively by the scrub
nurse. The nurse also denotes the biopsy location with the corresponding numbers in a histological
request. Afterwards, the biopsy samples and the request form are sent to pathology department for
histopathological confirmation resulting in a pathological TNM classification. The numbers are later
used by the surgeons to map the histological findings to the corresponding biopsy samples. Right
after the intervention the surgeon uses the DTTM to generate a clinical TNM classification and to
create an intervention report enriched with endoscopic images as well as schematic representations
from the larynx where the biopsy locations can be marked. An import of the DTTM report into the
local HIS was not possible, thus, the surgeons created an additional intervention report within the
HIS.
In order to facilitate and improve the aforementioned workflow and reduce documentation efforts
an integrated workflow between oncoflow, DTTM and SAP i.s.h.med has been implemented (see
Figure 6.2). Before a panendoscopy is performed, patient-specific information is already available
in oncoflow through the SAP i.s.h.med data export. After the panendoscopy, the surgeon opens the
EPR of the specific patient and creates a new panendoscopy data set. Subsequently, the surgeon is
able to open the DTTM application directly within oncoflow. Oncoflow then automatically transmits
Figure 4.2 – Typical setting during a panendoscopy. The surgeon uses an endoscope and a biopsy forceps
to obtain tissue samples through an esophagoscope
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the patient master data and the current case number to the DTTM so that the surgeon is relieved
from manually reentering existing information. Afterwards, the surgeon imports endoscopic images
from the intervention, creates the clinical TNM classification and generates the intervention report
as Portable Document Format (PDF) document in the DTTM. A dedicated network share for
importing PDF documents into SAP i.s.h.med was established where the generated intervention
reports are automatically stored. Based on the patient-specific case number which has to be the
beginning of the PDF’s file name the report is immediately imported by SAP i.s.h.med and included
into the patient record. Hence, surgeons are relieved from a time-consuming creation of additional
intervention reports within the HIS. Finally, the tumor classification, tumor location and endoscopic
images are automatically transferred to oncoflow for a centralized availability.
Unfortunately, the entire process for histopathological confirmation is not yet fully integrated
and supported. Further work will focus on the documentation of biopsy locations and correspond-
ing numbers within oncoflow during the intervention. In combination with the structured reports
from pathology department, assessments for the different biopsy samples which are clearly distin-
guishable according to their unique numbers could be directly mapped to the corresponding biopsy
locations. A convenient visual representation of the results would surgeons allow to hover over the
marked biopsy locations within the schema and see the corresponding pathological results for this
tissue sample.
4.4 Follow-up consultation
Follow-up consultations are crucial in cancer treatment to assure tumor clearance and to recognize
tumor recurrences at an early stage. This information is important for planning further therapies
in time in case of recidivisms. The documentation is also valuable for a long-term assessment
of therapy outcomes in order to perform retrospective clinical studies, hence, to improve tumor
therapy. Consultations are taking place quarterly the first year after therapy and every 6 months
the following 4 years. During the consultation the physician performs an examination of the oral
cavity and the hypopharynx, performs a tracheostoma check if present and asks the patient about
the current medical condition.
Patients with head and neck cancer experience partially severe functioning impairments after
tumor therapy. In addition, the patient’s way of life often does not change and risk factors such
as nicotine or alcohol abuse remain even after a complex tumor therapy. However, functioning
outcome and quality of life parameters are not regularly assessed in a standardized way in daily
clinical routine. Patient-reported outcome monitoring is an efficient way to capture quality of
life, fatigue, depression, medication side effects or disease symptoms for medical research and
daily clinical practice [22]. The necessary technology such as tablet computers and web-based
questionnaires are widely available in medical institutions so that the routine collection of patient
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data with a reduced amount of human resources is possible. Thus, the follow-up consultation process
has been enhanced with a tablet-based documentation system based on International Classification
of Functioning (ICF) practice guidelines (see Figure 4.3) and an improved results documentation
in oncoflow (see Figure 4.4).
Figure 4.3 – A questionnaire concerning quality of life criteria is digitally answered by patients prior
follow-up consultation with a tablet-based system
The assessment of the ICF based clinical practice guidelines was subject of a multicentric clinical
study [60, 61]. A shortlist of outcome instruments based on predefined criteria has been evaluated
by an interdisciplinary expert group. Afterwards, the experts agreed upon outcome measurement
instruments for 3 application areas (screening, therapy evaluation/planning, clinical trials). Finally,
a questionnaire has been developed based on the previous results and was implemented as Android
tablet application in order to facilitate the electronic results documentation. The development of
the Android application was realized by SWAN - Scientific Workflow Analysis GmbH.
Since then, the application is used before each follow-up consultation during the patient’s waiting
time which is frequently more than 30 minutes. During this time period nurses hand out tablets to the
patients in order to answer the questionnaire. Afterwards, the questionnaire results are automatically
imported into oncoflow and mapped to existing EPRs. Unfortunately, at the moment the information
is not instantly usable by the clinical staff. Hence, an integration of follow-up information into the
oncoflow user interface and an instant usability is work in progress.
The new approach enables the acquisition of information which is important for the evaluation
of therapy outcomes, for the conduction of clinical studies focusing on aspects of functioning
impairments after head and neck tumor therapy and finally for improving the therapy outcome
significantly.
Subsequently, the patient enters the examination room for follow-up consultation. During the
examination a nurse documents the results in SAP i.s.h.med (see Figure 4.4, left). Unfortunately,
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the documentation is performed in a free-form text field and important questions concerning current
nicotine or alcohol consumption are not asked. However, a structured follow-up documentation
form has been developed in oncoflow to improve the clinical workflow and the information quality
(see Figure 4.4, right).
Figure 4.4 – left: The follow-up documentation in SAP i.s.h.med is conducted in an unstructured free-form
text field; right: oncoflow provides a structured documentation of dates, actual risk factors
and recidivism occurrence
Information availability and information quality are improved by 3 check boxes for alcohol and
nicotine consumption as well as for tumor recurrence. This information allows retrospective clinical
studies where tumor type, therapy, way of life and tumor recidivisms can be correlated over time.
The clinical workflow is supported by using distinct date fields containing the consultation date as
well as the date for reassessment. Particularly the reassessment date can be used for automatically
generating patient lists for the upcoming follow-up consultation or to limit the number of patients
scheduled for a specific date. A button +3 Months (Wednesday) increases the date for the
next consultation each time by 3 months and facilitates the scheduling process. However, the tablet-
based documentation and the structured follow-up documentation in oncoflow have to be merged
so that only one consistent documentation will be used in the future.
4.5 Treatment guidance
The treatment guidance is rather a set of tools supporting daily clinical routine from the viewpoint of
the attending physician than a single Web page in oncoflow and accompanies the patient throughout
the entire treatment process beginning at the registration for the first consultation until the patient is
released from follow-up meetings. Depending on the patient’s current stage in the treatment process
there are several tasks for the physician (see Table 4.1).
These tasks will be soon implemented in oncoflow as work list. Based on key events in the
treatment process the patient status will be automatically updated in oncoflow and the patient
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Table 4.1 – oncoflow work list items and corresponding tasks for the attending physician in daily clinical
routine. Descriptions of the respective work list item are depicted in italic, physician’s tasks in
standard typeface
Work list items in oncoflow Description and physician tasks
New patient Create new patient record
Schedule patient for anamnesis
Anamnesis Anamnesis and clinical examination performed
Creating diagnoses based on observations
Schedule patient for panendoscopy
Panendoscopy Panendoscopy performed
Create intervention documentation
Create TNM classification in DTTM
Annotate endoscopy images in DTTM
Upload tumor documentation to oncoflow
Pathology Histopathological report available
Schedule patient for next tumor board
Tumor board Therapy decision available
Schedule patient for therapy
Follow-up Follow-up consultation
Schedule patient for next follow-up
Export patient information for survival analysis
moves to another work list item. These events may be an upload of panendoscopy information
from DTTM into oncoflow, the availability of new histopathological reports or the discussion of
the specific patient in the local tumor board. The work list supports the physician with an improved
access to different groups of patients in daily clinical routine. An important use case example is
the scheduling of patients for pre-operative tumor boards. Hereby, the trigger is the availability
of histopathological results for the specific patient. Hence, oncoflow will provide an overview
including all patients that have to be scheduled for upcoming tumor boards. The creation of tumor
board invitations can be started immediately from this patient overview with the help of a new
method described in Chapter 5.
4.6 Treatment summary
An overview of the current medical status of a patient is crucial, especially for physicians which
are not familiar with their actual patient. The overview should present information important for
physicians in the current treatment step. These information entities in the field of tumor therapy may
be diagnoses, applied medical procedures, histopathological results as well as surgical intervention
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or radiochemotherapy outcomes. This information is already available in digital form within the
clinical information systems. Unfortunately, the information is not presented in an appropriate
manner, hence, not visible for the physician at a glance.
In order to mitigate these drawbacks physicians and surgeons from the Inselspital in Bern,
Switzerland, manually prepare relevant patient-specific information in a text document (see Figure
4.5). This patient summary is continued by each attending physician who manually reenters impor-
tant information already available in the local HIS. The presented approach shows the significance
of the problem but is also time-consuming and error-prone.
Figure 4.5 – A treatment summary used at the Inselspital in Bern which is generated and updated manually
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The treatment summary in oncoflow addresses this issue and provides a condensed patient
overview summarizing the most important information in the current treatment phase (see Figure
4.6). A prototypic rule-based implementation aggregates the latest information available originating
from each process step into a one-page overview. The overview contains textual information as well
as medical images from panendoscopy structured according to the oncological treatment process.
The treatment summary should be more focused on the information which is relevant in the current
treatment step. Thus, a dynamic framework which is aware of the patient’s actual situation and
which is able to restructure the visible content should be the next development step. However, the
HMM-based approach presented in Chapter 7 builds the basis for further research in this field.
Figure 4.6 – The treatment summary gives a brief overview on the patient’s current medical status. The
automatically generated treatment summary in oncoflow has a clear structure and provides
additional information in form of medical images
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4.7 Information aggregation and data export
The support of clinical studies and quality management is one major requirement for oncoflow.
Therefore, a full-automatic information import was established as depicted in Chapter 3 and new
approaches were implemented and tested to acquire important information in a structured way as
shown in Section 4.2, Section 4.3 or in Chapter 5. However, this information is only valuable for
physicians and surgeons when they are able to select, aggregate and export relevant data according
to their actual needs in a convenient way. Therefore, a module has been developed for oncoflow
which allows a convenient access to existing information [62].
Requirements analysis The module development started with a detailed requirements anal-
ysis together with physicians and surgeons involved in head and neck tumor treatment. Hereby
two major aspects for information export could be identified. In order to process huge amounts
of patient data for statistical analysis the SPSS software suite is used. Therefore, the selection of
patients with specific characteristics (e.g. blood count or alcohol consumption) within a defined
time period and a following export as MS Excel sheet are needed. Within a second use-case scenario
an online evaluation and processing of patient information is necessary where a predefined set of
clinical questions is provided and the query results are immediately visible within the web-browser
as depicted in Figure 4.7 for the average age of patients.
Figure 4.7 – The age structure of patients is instantly available in the web-browser
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The questions for online evaluation could be divided into three categories and are depicted in
detail in Table 4.2:
• Clinical workflow support
• Clinical studies
• Quality management and clinical certification
In the area of clinical workflow support the system helps physicians to keep track of patients that
are temporarily treated in a different department in order to assure the subsequent treatment in the
head and neck department. An example are patients which received a surgical intervention with
subsequent adjuvant radiotherapy or chemotherapy. Sometimes, these patients are not sent back
to head and neck department to be scheduled for follow-up consultations. The identification of
these patients could be facilitated in oncoflow so that an appropriate follow-up care can be assured
(see Table 4.2, question 10). Furthermore, all tumor patients should undergo a hearing test, hence,
question 9 aims to identify patients with no test.
Table 4.2 – Relevant clinical questions from physicians and surgeons during the oncological treatment
process
No. Question Description
1 Tumor boards (TB) Patients cases discussed in pre- or posttherapeutic tumor boards com-
pared to the number of all patients
2 First procedure Date of the first applied procedure from patients whose first consulta-
tion was performed at most X days ago
3 No. of patients in TBs Average number of patients in the tumor board per month
4 First consultation Number of first consultations per month
5 HPV16 indicator Histology reports containing information about the HPV16 status of
a patient
6 TB decisions List of therapy decisions in tumor boards including absolute and rela-
tive frequency of each decision
7 Time to first TB Time in days between first consultation and first tumor board
8 Time to first therapy Time in days between first consultation and first therapy
9 Aural examination Patients which had no hearing test
10 Follow-up tracking Identification of patients who had an adjuvant therapy but not yet
a follow-up appointment or where the timeframe between the last
therapy and the first follow-up consultation is larger than 5 month
11 ICD10 finder Find all patients where a specific ICD10 code was assigned
12 ICD10 counter How frequent was a specific ICD10 assigned, differentiated according
to gender, alcohol or nicotine consumption
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In the field of research and clinical studies the evaluation module supports the identification of
patients with specific attributes. Latest research focuses on the connection between HPV161 status,
smoking and alcohol habits and oropharyngeal cancer. Unfortunately, in the current information
systems the identification of patients with HPV16 status is not possible, but the evaluation module
allows the selection of patients with a HPV16 status in their histopathological results (see question
5).
Questions of the third category focus on quality management and clinical certification aspects.
Clinical certification procedures, e.g. cancer center certification from the DKG [63], demand a struc-
tured documentation and evidence of time-frames during the tumor treatment as well as detailed
information about tumor board conduction. Questions 7 and 8 focus on the time elapsed between
the first consultation and the first tumor board or the time between the first consultation and the
first applied therapy procedure. Question 1 evaluates the fraction of tumor patient cases discussed
in the tumor board compared to all tumor patients. In this example the discussion of at least 95%
of all patients in the tumor board is necessary to meet the DKG criteria.
Technical realization According to the results of the requirements analysis a new oncoflow
module was developed that seamlessly integrates into the existing framework. A request catalog lists
all clinical requirements depicted in Table 4.2. The questions are persisted in the oncoflow database
and consist of a 3-tuple of information. The first part contains the SQL string which is later used
for the database query. The second part of the tuple contains information about the user interface
in the web-browser. Details such as parameter fields where the clinical staff is able to adjust query
parameters or detailed descriptions of the current query are defined here. In the last part possible
visual representations for the results and corresponding parameters such as axis labels for the charts
are defined. Most results can be displayed as table, bar chart or pie chart. This modular concept
allows an improved modification of existing queries as well as a facilitated implementation of new
clinical requirements. All changes can be performed during live operation without a re-compilation
and a re-deploy of the oncoflow system.
Figure 4.8 – Tumor board decisions sorted according to their frequency of occurrence
1Infection with the human papillomavirus (HPV) 16 are cause of a unique type of throat cancer
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4.7. INFORMATION AGGREGATION AND DATA EXPORT
The results are presented tailored to the specific use-case. Figure 4.8 depicts results presented as
table (see Figure 4.8).
Tables can also be saved as Excel file for further usage. The automatic aggregation of information
is also conveniently usable for the creation of scientific publications or quality management reports.
Therefore, bar-charts and pie-charts are automatically generated (see Figure 4.7 and Figure 4.9).
The figures are instantly available for download as pixel graphic (jpg, png) or as vector graphic
(svg). The HighCharts Java Script library is used to generate the figures.
Figure 4.9 – The ICD10 counter gives a brief overview on the relative frequencies of used ICD10 codes.
The diagram shows the distribution of ICD tumor codes for N=511 patients in 2013 and
2014. The exact numbers are displayed while hovering over the different segments of the pie.
The ICD10 codes C00 – C32 denote head and neck tumors, C34, C78 denote tumors of the
respiratory and digestive systems, C41 – C73 denote tumors of bone, skin, kidney and thyroid
gland, C77 denotes tumors in the lymph nodes and C76, C78, C79 and C80 denote tumors
that are not defined in detail
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Chapter 5
Treatment Planning Unit
5.1 Introduction
Tumor boards are a generally accepted institution in tumor therapy so that upcoming clinical cer-
tifications from the German cancer association DKG make high demands on the conduction of
tumor conferences [63]. On the other hand scientific research projects with varying results assessed
whether the presence of tumor boards can be associated with improved treatment decisions or ther-
apy outcomes [64, 65, 66]. The existing requirements to cancer centers and the few compelling
studies about the outcome of tumor boards built the basis for the implementation of a comprehen-
sive tumor board assistance module at the University Medical Center Leipzig [54, 67]. The module
supports the entire tumor board management process including patient scheduling as well as in-
vitation and protocol mailings. Intelligent results documentation during the board and automatic
physician registration in the meeting room make the decision-making process more transparent
and are first steps towards a clinical certification as cancer center (requirements of the DKG are
depicted in detail in Table 5.1). In order to improve the common understanding additional patient
information and medical images were included into the patient presentation based on the work of
Simo et al. [68].
The following sections describe in detail all steps which were performed to efficiently support
the management of our weekly tumor boards [69]. Furthermore, all technical assistance functions
which are used during the tumor board conduction to support the decision-making process and to
improve the information acquisition for cancer center certification are depicted.
5.2 Tumor board management support
The time-consuming process for tumor board management which includes invitation mailing, man-
ual transcription of tumor board results and final tumor board protocol mailing has been improved
significantly with oncoflow.
The weekly tumor board takes place on Thursday. The established process for scheduling patients
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Table 5.1 – Requirements of the DKG on tumor boards. The description is highlighted in italic, the on-
coflow support is depicted in standard typeface
Requirement Description, oncoflow support
Tumor board cycle At least one tumor board must take place in a week.
The schedule of tumor boards is documented in oncoflow.
Tumor board preparation All patient-related information has to be gathered before the board.
The structured anamnesis and clinical examination as well as the automatic
information import from HIS and DTTM guarantee the availability of all relevant
patient-specific information in oncoflow.
Pretherapeutic board 95% of all primary patients have to be presented in the pretherapeutic tumor
board.
An evaluation of this characteristic number is possible with oncoflow.
Tumor board invitation Relevant patient information has to be distributed to all board participants be-
forehand.
A condensed view of existing patient-specific information helps the physician in
the creation of board invitations. The invitation letters are afterwards automati-
cally sent as PDF document via email to all registered board participants.
Tumor board participants Specialties from diagnosis, surgery, radio oncology, oncology, radiology and
pathology must be present in each board.
All participants are registered via RFID in the TPU and stored in the oncoflow
database for documentation purpose.
Medical images Patient-specific medical images (pathology, radiology) must be present and pre-
sented with an appropriate technical infrastructure.
Images from panendoscopy and 3d tumor reconstructions are available in on-
coflow and presented within the TPU.
Tumor board protocol The tumor board protocol consists amongst others of an interdisciplinary treat-
ment plan and should be immediately generated from the tumor documentation
system.
oncoflow and the TPU are used for result documentation during tumor board
conduction. Given information in the invitation letter are subsequently enriched
with board decisions and automatically sent via email as a PDF document to all
board participants.
Therapy deviation The tumor board therapy decision is obligatory. Therapy deviations and therapy
changes at the will of the patient have to be documented.
The documentation of therapy changes is not yet implemented into the therapy
workflow of oncoflow but scheduled for further development.
and sending invitations and protocols was as follows: Patients with histological confirmed tumor
(ICD-O-M catalog) are scheduled for the next upcoming tumor board. Therefore, physicians from
head and neck surgery used MS-Word templates, searched relevant information in the HIS and
manually transferred the information into the template. Subsequently, the template was stored on
a common network share. The deadline for patient scheduling is Wednesday noon. Afterwards, a
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physician converted all Word documents into PDF format, created an email addressed to all tumor
board participants, attached the PDF invitations and sent the mail. During the tumor conference an
assistant physician presents the patient cases and documents the therapy decisions for each patient.
Afterwards, the assistant physician manually reentered the therapy decisions into the existing Word
files, created a second PDF file as tumor board protocol and sent the protocol to all participants.
Unfortunately, the tumor board decisions were not centrally available in the HIS but only in the
email inboxes.
In order to improve the workflow a dedicated tumor board module has been developed which
assists the physician in each step. Firstly, the Word template has been implemented as structured
form in oncoflow which is accessible within the EPR in the web-browser. The tumor board invita-
tions are automatically pre-populated with existing information about recent diagnostic procedures
and histopathological results. Additional information is visible at a glance so that the invitation
form can be conveniently enriched with further patient details. Afterwards, on Wednesday noon the
final invitation PDF files are automatically created with LATEX with one button click in oncoflow
and sent as email to all physicians and surgeons participating the tumor board. The email contains
direct URLs to the specific electronic patient records in oncoflow and the PDF documents of all
invitations. The therapy decisions during the tumor board are immediately documented by the
assistant physician with an Android tablet and are stored in the particular EPR in oncoflow. Thus,
the tumor board protocols can be immediately created and sent via email to all participants after
the tumor conference has finished. The PDF files are also automatically imported into the patient’s
electronic patient record in the HIS to make the therapy decisions available for all attending physi-
cians. Therefore, oncoflow saves a copy of each protocol into a dedicated folder from where SAP
i.s.h.med regularly imports new documents.
5.3 A novel approach for meeting room design
The regular tumor boards take place in a meeting room at the radiology department of the Univer-
sity Medical Center Leipzig (see Figure 5.1). The room consists of two rearward projectors for
displaying CT and MRI tomographic images on a large screen in front of the audience. The seating
arrangements are chosen in a way that the audience view is directed to the screen. In the front
right corner of the room a desk for the radiologist is situated from where the tomographic images
are selected for presentation and the radiologist explains the diagnostic findings to the audience.
During the meetings, the seats are manned according to the clinical hierarchy. Professors and senior
physicians are sitting in the front while assistant physicians and students are sitting in the back of
the meeting room.
The current setting reveals several drawbacks. The aim of a tumor board is an interdisciplinary
discussion of possible therapy options in order to find the best possible therapy for the patient.
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Figure 5.1 – Meeting room for regular tumor boards with strong hierarchical seating arrangements
However, the orientation of the seats in direction to the screen demands that the physicians on the
front seats have to turn for discussing therapy options with their colleagues. But, unfortunately,
the professors and senior physicians rather talk in direction of the screen and the radiologist. In
combination with the noise of the projectors physicians and assistant physicians in the back are
hardly able to follow the discussion or contribute their point of view. A detailed analysis of the
influence of the clinical hierarchy was conducted by Lassalle et al. and served as important basis
for this work [70].
Finally, the presentation of further patient-specific or therapy-decision related information is
hardly possible, because the projectors are used by the radiologist. Actually, there is additional
information available to facilitate the decision for a specific therapy. Endoscopic images showing
the tumor may be more meaningful to medical disciplines like pathologists or radiotherapists
than CT or MRI slices. A picture of the patient may give an impression of the patient’s current
constitution and decrease possible options for chemotherapy or radiotherapy. Unfortunately, this
information is not available during tumor boards.
In order to improve the aforementioned drawbacks an entirely new concept for tumor board
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meeting room design has been developed. Hereby, the meeting room concept and the engineering
tasks such as hardware installation in the meeting room were conducted by my colleague Stefan
Bohn [54]. A seating arrangement was developed with all medical disciplines which use the meeting
room (see Figure 5.2). The V-style seating arrangement provides improvements for collaborative
discussions and was accepted by all parties and could finally be realized. Apart from the seating
arrangements further improvements in the meeting room are conducted such as the installation of
two 50 inch plasma screens beside the large projector screens. On the screens additional information
like patient information, panendoscopy images or medical images from nuclear medicine are shown.
Figure 5.2 – A novel approach for meeting room design with V-style seating arrangement. Image printed
with kind permission from Stefan Bohn
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Finally, the automatic documentation of tumor board participants should be mentioned here.
Requirements from the DKG are that specific clinical disciplines must join the regular tumor
boards. In order to facilitate the documentation a RFID reader has been integrated at the meeting
room entrance. The employee identification badges contain a RFID chip which transmits a unique
identifier. Thus, physicians and surgeons put their badge on the RFID reader when they enter the
room so that the presence is recognized in oncoflow. For the first time, a new physician or surgeon
joins the conference, the unique badge identifier is shown in oncoflow and can be connected with
an existing user profile or used to create a new user. Each user has assigned a clinical position (e.g.
assistant physician or professor) as well as the associated department. Based on this information
detailed reports about the presence of clinical disciplines and the hierarchy of the participating
physicians can be generated for clinical certification purposes.
5.4 Conclusions
Figure 5.3 shows a photo of the new meeting room. In addition to the new plasma screens one can
see a new light concept for the room. Initially, the idea was to support the decision-making process
with different light schemes for the patient case presentation phase and the decision-making phase.
A scientific evaluation of this concept with the help of psychologists is unfortunately pending due
to a lacking interest on this topic.
Figure 5.3 – The sophisticated tumor board design with additional screens for case and endoscopic image
presentation and a new lighting concept
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Comparing the functionalities of the TPU with the tumor board requirements depicted in Section
2.3 and Table 5.1 reveals that not all requirements are fulfilled. Fortunately, nearly all DKG re-
quirements presented in Table 5.1 are met. There are weekly tumor boards where all patient-related
information is presented in a structured way. Medical images from different imaging modalities are
presented during the tumor board and a protocol with the therapy decision is sent to all participants.
The requested documentation of a therapy deviation is not available at the moment.
The requirements in Section 2.3 cover a broader range of functions. At the moment, the TPU
is lacking an active patient participation, a robust mechanism for prospective assessment of tumor
board performance and reliable interfaces with primary care to ensure continuity of care. Further-
more, patients do not have the ability to fully explore all their available therapy options and the
screening of eligible patients for recruitment into ongoing trials in real time is yet not possible and
are topics of ongoing research and development.
However, the TPU is an entirely new approach to support the conduction of tumor boards and to
make the results documentation process more efficient. The endoscopic images are very valuable
to clarify the tumor location and the tumor extension so that all tumor board participants achieve a
common understanding of the current medical situation and are able to contribute equally to find
the best possible therapy for the patient. An example for the importance of endoscopic images are
vocal fold carcinomas with extensions less than 5 mm which are not visible on regular CT scans
(see Figure 5.4).
Figure 5.4 – Endoscopic image from carcinoma that are not visible on CT scans. left: a vocal fold carci-
noma on the left vocal fold; right: tumor on the tip of the tongue
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Chapter 6
Clinical application and evaluation
6.1 Deployment of oncoflow at a clinical site
The design and implementation of oncoflow has been realized in close collaboration with the
department of head and neck surgery at the university medical center in Leipzig, Germany. The
concept of a web-based central information base with clinical workflow as well as tumor board
support started in 2011. The first prototype of oncoflow has been deployed for tests in daily clinical
routine in October 2012. The system runs on a virtual Linux server at the IT department of the
hospital and is accessible at each personal computer in the clinic via web-browser. During an
initial trial phase at the clinical site shortcomings in the user interface, the HIS data export and the
communication interface to the DTTM have been identified and fixed.
Since November 2012 oncoflow is being used in daily clinical routine for the documentation of
anamnesis and clinical examination of patients with tumor suspect (see Figure 6.1, left) and the
upload of panendoscopy results as well as the documentation of the intervention in combination
Figure 6.1 – left: documentation of anamnesis and clinical examination results in oncoflow, right: patient
summary and endoscopic images are shown additionally to CT images in the tumor board
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with the DTTM. Diagnoses, applied medical procedures, histopathological results and radiological
reports are imported automatically so that all relevant information for the decision-making process
in the tumor board are completely available inside the oncoflow EPR. The first usage of oncoflow
together with the TPU to support the local head and neck tumor board was in February 2013 in
the conference room at the radiology department of the university medical center Leipzig (see
Figure 6.1, right). The new light concept with changing colors depending on the actual discussion
phase, the presentation of endoscopic images and 3-dimensional tumor reconstructions at two 50-
inch plasma screens and the new results documentation were well-accepted by the participating
physicians and surgeons. Between March 2013 and August 2014 590 patient cases were scheduled
for tumor boards with complete oncoflow, Moboco and TPU support.
The interconnection of oncoflow with all adjacent systems in the local hospital IT infrastructure
is depicted in Figure 6.2. The Figure also shows the four main workflow steps improved with
oncoflow and the TPU and the software products that are used in each process step. The model was
created with the 3LGM2 toolbox developed at the IMISE at the Universität Leipzig [71].
6.2 Study design
The study focused on the documentation process of first anamnesis and clinical examination of
patients with suspected head and neck tumor depicted in detail in Section 4.2. The clinical study
has been performed in the department of head and neck surgery at the university medical center
Leipzig between November 2012 and April 2013 and consists of three independent parts which are
published in [72, 73].
The qualitative and quantitative parts of the study focus on the following three statements or
hypotheses. Points one and two will be evaluated with the questionnaire and the third point will be
quantitatively evaluated with the workflow analysis.
• The browser-based user interface will be accepted by the clinical staff due to a convenient
handling and shorter response times compared to the HIS
• The provision of a structured form for result documentation gives the attending physician a
guideline and relieves from using additional documents
• The usage of a web-based form for documenting first consultation results needs an equal
amount of time than the documentation in SAP i.s.h.med
6.2.1 Quantitative evaluation
In the first part a detailed analysis of the current anamnesis workflow with the HIS as well as an
analysis of the usage of oncoflow has been performed. Hereby the time stamps of each process
step and the questions that were asked to the patient have been documented in detail. This part
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Figure 6.2 – The 3-tier architecture shows the interconnection of oncoflow with all adjacent systems on a
physical layer (bottom), software layer (middle) and a functional layer (top)
of the study was performed using the s.w.an-Suite from SWAN – Scientific Workflow Analysis
GmbH [74, 37]. The suite includes a workflow configurator that provides a graphical user interface
for the definition of clinical workflows. These workflows consist of actors, activities and events.
For this study one actor (physician) has been defined. Activities consisting of a start and end time
as well as events representing one point in time can be assigned to each actor. Thus, based on
the respective workflows depicted in the following paragraph about the questionnaire design, two
different configurations for the documentation of the control group and experimental group have
been created. The workflow recordings were performed with the workflow editor from the s.w.an-
Suite on a Microsoft Windows XP tablet computer with a stylus pen as input device (see Figure 6.3,
right). The documentation took place at the clinical site in an examination room at the head and
neck department (see Figure 6.1, left). Therefore, the author of this thesis observed the anamnesis
and clinical examination process and documented all occurring activities and events. The final
workflows are stored as XML files that can be automatically imported into a PostgreSQL database
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for further processing such as an automatic evaluation of activity times that can be used afterwards
for statistical analysis.
Figure 6.3 – User interface of the s.w.an workflow editor
6.2.2 Qualitative evaluation
A questionnaire-based investigation states the second part of the study and should evaluate a quali-
tative acceptance level of the new system compared to the current workflow. The questionnaire has
been developed according to [75]. The questionnaire focuses on two major aspects with regard to
the study hypotheses denoted in bullet points one and two:
• Acceptance of the structured web-based user interface compared to the unintuitive old-
fashioned user interface of the HIS
• Does the structured documentation form of oncoflow improve the working process of the
physician compared to a free-text field with the usage of additional helper documents in the
conventional HIS
Hence, the questionnaire is separated into two major parts whereby the first part addresses the
current working process with the HIS and the second part is focused on the usage of oncoflow.
Each of these parts consists of eleven questions. An additional third part of the questionnaire
aims to determine the overall satisfaction with oncoflow. The answers of the first two parts of the
questionnaire were realized with a Likert scale consisting of five choices between 5 (strongly agree)
and 1 (strongly disagree) [76]. The Likert scale of the last question part also consists of 5 choices
but the answers range from 5 (very good) to 1 (very bad). The questions and corresponding answers
are depicted in detail in Section 6.4.
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6.2.3 Workflow distance evaluation
The third part of the study focused on the improvement of information quality which results from
a structured documentation process. Therefore, the Levenshtein distance was applied to the data
which originates from the clinical workflow analysis in order to show improvements in the docu-
mentation process so that the acquired data is more structured and exhaustive. The analysis focused
on the points depicted as captions in the web-based anamnesis form (see Table 6.1).
The study hypothesis for the third part of this study is as follows: “A structured documentation
with a predefined set of questions results in a more structured and standardized clinical workflow,
an EPR containing more relevant patient-specific data, hence, a higher information density.”
Table 6.1 – Study-relevant observation parameters depicted in ideal chronological order (gold standard)
Question type Description
Actual anamnesis Reason for going to the clinic and actual problems.
ENT anamnesis ENT specific questions.
Common anamnesis Information apart from ENT, e.g. herpes, cramps, etc.
Interventions All former interventions.
Allergies Information about existing allergies.
Drugs Which drugs the patient uses regularly.
Profession Profession of the patient, especially interesting in the case of potential
tumor risk factors.
Family anamnesis Diseases from family members, especially tumor diseases.
Nicotine Nicotine consumption.
Alcohol Alcohol consumption.
6.3 Experimental setup
6.3.1 Anamnesis and clinical examination process
The consultation consisting of anamnesis and clinical examination is actually performed by all
physicians with a similar approach. If necessary the physician starts with a preparation of the
consultation by opening the EPR, reading physician letters or importing medical images from a
compact disc into the local PACS. Afterwards, the patient enters the examination room and the
physician starts asking questions to the patient and simultaneously enters relevant information into
the HIS. The clinical examination follows, then the patient leaves the room and finally the physician
enters the examination results into the HIS.
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The usage of oncoflow for results documentation leads to minor changes in the current workflow.
During the preparation phase the physician opens the oncoflow patient record additionally to the
HIS patient record. Unfortunately, due to lacking bi-directional communication interfaces from
oncoflow to the HIS, the physician needs to copy & paste the consultation results from oncoflow to
the HIS after the consultation (see Figure 6.4).
6.3.2 Postprocessing and analysis
The time measurement study investigated the influence of a new approach for results documentation
on the amount of time a physician needs for performing anamnesis and clinical examination. The
study will show that the new documentation system does not impair this process step. Therefore, the
statistical evaluation focuses on the overall duration of the process and the amount of time needed
for results documentation. The documentation time in the experimental group consists hereby of
the sum of the time needed for documentation in oncoflow and the transfer time to the HIS. The
following approach was used for the statistical evaluation of both overall workflow times as well as
only documentation times. The open source software environment R has been used for all statistical
calculations [77, 78].
Given two samples x1, . . . , xm and y1, . . . , yn that denote time measurement values from the
control group and the experimental group, respectively. It has to be shown that both samples do not
differ significantly from each other, hence, are from the same population. At first the Shapiro-Wilk
test with significance level α = 0.05 was applied in order to show the normality distribution for
both samples [79].
The F-test is then used for the evaluation of the variances of the given populations [80]. If the
variances are equal (F-value between lower critical value flow and upper critical value fup) the T-test,
otherwise the Welch-test has to be used for the final comparison of both distributions. Both T-test
and Welch-test are designed for small sample sizes [81]. The final result parameter of these tests
is the t-value. The goal is to show that |t| < t∗ is true, where t∗ is the critical parameter, meaning
that the two sample groups are from the same population. For oncoflow this would mean that there
is no significant impact on the anamnesis and clinical examination workflow of the physician. The
critical parameters for the Shapiro-Wilk, F, T and Welch-test with significance level α = 0.05 can
be found in reference tables [79, 82].
The evaluation part for the Levenshtein distance measure study has been performed with a text-
based Java application and a study file format especially developed for this project. The input file
consists of a gold standard describing the ideal order of questions in the first line and the patient-
specific observations in the following lines. The ideal order of questions equals the order used in
Table 6.1 with a total number of 10 observations. The Java program processes two separate input
files containing SAP i.s.h.med and oncoflow results and calculates the Levenshtein distance for each
patient-specific observation with respect to the gold standard. The program also performs a statisti-
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Figure 6.4 – The workflow for anamnesis and clinical examination during the clinical study with oncoflow
cal evaluation of the results. It calculates mean and median values, variance, and standard deviation.
Afterwards, a Mann-Whitney U test is performed in order to show the statistical significance of the
results.
6.4 Qualitative evaluation of the therapy process
The following three figures depict in detail the questions, results and median values of the question-
naire.
During the study five physicians used oncoflow and participated in the survey (n = 5). In each
Figure 6.5 – Questions concerning the conventional HIS (SAP i.s.h.med)
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figure the questions are depicted on the left side and the corresponding answers in percent are
shown as horizontal bars on the right side. The scale on the bottom corresponds to the answers.
The gray circles included in each horizontal bar show the Likert median value of the respective
question.
Figure 6.6 – Questions concerning the usage of oncoflow
The answers are sorted descending according to the Likert median value. The first three questions
in Figure 6.5 address the topics usability and support. The results show that the user needs many
mouse clicks in SAP i.s.h.med (m = 5), that relevant patient information is hard to find (m = 3)
and that the physician frequently uses additional documents for anamnesis and clinical examina-
tion documentation (m = 4). Compared to the results depicted in Figure 6.6 exactly these three
questions gain actually the lowest average ratings in oncoflow (m = 3;m = 3;m = 2). Questions
focusing on the user interface in Figure 6.5 depict that SAP i.s.h.med receives low ratings for an
intuitive (m = 2), well arranged (m = 2), and responsive (m = 1) user interface. The oncoflow
user interface however has been judged as well arranged (m = 5), responsive (m = 5) and intuitive
(m = 4) as can be seen in Figure 6.6. The remaining sets of five questions evaluate the workflow
support for both systems. The SAP i.s.h.med ambulance card does not provide documentation sup-
port (m = 2) and the free-form text field is less helpful for information documentation (m = 2) and
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the documentation workload is high (m = 2). Also the training time for getting familiar with SAP
i.s.h.med was relatively high (m = 2) and the electronic patient record is unstructured (m = 2).
The new developed anamnesis and clinical examination documentation form in oncoflow supports
the clinical process well (m = 4), supports the documentation process (m = 4) and minimizes
the documentation workload (m = 4). The electronic patient record in oncoflow is well-structured
(m = 4) and the training time for the system is low (m = 4).
Figure 6.7 – Four questions evaluated the overall satisfaction of the surgeons with the oncoflow system
whereby the three points denote space for the chosen answer
Finally, the questions regarding the overall user acceptance of oncoflow depicted in Figure 6.7
show that the users are very satisfied with the new information system. Oncoflow works well
(m = 4) and corresponds very well to their expectations (m = 5). All users could imagine keeping
on using the system in the future for the documentation of anamnesis and clinical examination
(m = 5). The new designed documentation form supports the work of the physician (m = 4).
6.5 Quantitative evaluation of the therapy process
The detailed investigation of workflow times for anamnesis and clinical examination has been con-
ducted within a control group that used the conventional documentation method with the HIS and
an experimental group that used oncoflow for the results documentation. Altogether 25 workflows
have been documented and are depicted in Table 6.2 (control group, 14 workflows) and Table 6.3
(experimental group, 11 workflows). Eleven additional workflows had to be excluded from the eval-
uation because they were incomplete or faulty because of the unpredictable daily clinical routine
such as the arrival of emergency patients. The column “Overall duration” in Table 6.2 and Table
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6.3 is not the sum of the following table columns. The column depicts the time between the start
and the end of the workflow recording and includes small time slots between the different process
phases. This is e.g. the time after the finished anamnesis part when the physician goes to the patient
and begins the clinical examination.
Table 6.2 – Overall time and times for the different process steps recorded during the usage of SAP
i.s.h.med for results documentation. All times are depicted in minutes
Workflow
number
Overall
duration
Preparation Anamnesis Exmination Documentation
in HIS
Interceptions
1 11:06 00:00 02:09 03:28 03:57 00:00
2 14:10 00:00 05:33 05:49 07:17 00:00
3 17:44 00:00 05:20 05:02 10:26 00:11
4 19:03 02:00 09:19 04:29 08:43 00:28
5 20:17 00:00 04:28 05:11 07:15 00:34
6 20:37 05:20 00:41 06:06 01:08 00:22
7 22:04 00:36 08:10 04:55 13:34 01:08
8 22:24 01:00 09:46 07:03 12:55 03:27
9 23:07 01:24 07:08 03:41 01:36 01:53
10 24:24 03:11 03:15 11:24 06:49 01:23
11 28:41 08:21 05:10 06:13 06:27 00:59
12 31:26 00:21 06:26 13:57 10:13 07:20
13 32:01 13:32 08:00 05:37 06:47 01:21
14 43:49 09:12 11:49 07:04 14:17 00:46
Mean 23:38 03:13 06:14 06:26 07:57 01:25
Std. dev. 08:17 04:17 03:04 02:54 04:05 01:56
Median 22:14 01:12 06:00 05:43 07:16 00:53
The mean values for the overall duration are 23:38 minutes for HIS and 25:48 minutes for
oncoflow and the median values are 22:14 minutes and 22:10 minutes respectively. Despite an
additional copy & paste step during the usage of oncoflow the HIS documentation is only 8.4%
faster in the mean and actually 0.3% slower in the median value. The pure time where the physician
is sitting in front of the computer and enters information is in the main focus for time measurement
(see gray shaded result values in Table 6.2 and Table 6.3). Comparing the median values from
7:57 minutes with the HIS and 8:40 with oncoflow shows that the documentation in oncoflow lasts
8.1% longer. The median value for the documentation in the HIS is 7:16 minutes and in oncoflow
7:21 minutes which means that the documentation in oncoflow is 1.1% or 5 seconds slower than in
the HIS. When the additional time for the transfer of the information from oncoflow to the HIS is
considered the overall documentation in oncoflow is 17.9% slower in the mean and 8.5% slower in
in the median value. Statistical tests as depicted in section Section 6.3.2 are now used to evaluate if
the recorded workflow samples show significant differences. The Shapiro-Wilk-test, which had to
be applied first, proved the normality distribution for all samples. Subsequently the F-test has been
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Table 6.3 – Overall time and times for the different process steps recorded during the usage of oncoflow
for results documentation. All times are depicted in minutes
Workflow
number
Overall
duration
Preparation Anamnesis Exmination Documen-
tation in
oncoflow
Transfer to
HIS
Inter-
ceptions
1 29:13 05:18 08:47 09:02 02:59 02:13 00:00
2 19:18 03:54 05:41 03:49 07:21 00:36 01:51
3 36:17 08:52 11:27 06:12 16:34 02:13 00:35
4 31:46 04:49 04:36 02:04 05:28 01:41 16:31
5 24:19 01:48 06:41 06:54 10:44 02:05 02:36
6 19:41 02:59 04:10 08:13 05:20 00:18 03:33
7 22:10 00:00 08:20 06:19 11:23 00:22 03:00
8 16:25 00:55 03:17 06:32 07:00 00:08 01:34
9 43:13 03:01 10:03 07:53 12:47 01:43 15:17
10 20:34 01:08 08:16 05:57 09:27 00:07 00:17
11 20:48 06:20 06:34 03:02 06:12 00:00 03:35
Mean 25:48 03:33 07:05 06:00 08:40 01:02 04:26
Std. dev. 08:21 02:39 02:33 02:11 03:57 00:56 05:48
Median 22:10 03:01 06:41 06:19 07:21 00:36 02:36
used for comparing the samples standard deviation. The F-values (1.0148 for the complete workflow,
1.1072 for documentation only) have been between the critical values flow = 0.308,fup = 3.25;
hence, the standard deviations are not differing significantly. Based on the F-test results the T-
test has to be used for finally comparing the workflows. Both T-test results show that |t| < t∗
[t1 = −0.6451, t2 = −1.0344, t∗ = 1.714] whereby t∗ is the critical value of 1.714; thus, there is
no significant difference between the workflows.
6.6 Workflow evaluation using Levenshtein distance
6.6.1 Background: Levenshtein distance
The Levenshtein distance has been developed to compare the similarity between two strings, thus
also denoted as string edit distance [83]. Schumann et. al. compared the Levenshtein distance,
the Jaccard distance [84], the Adjacency distance [85] and the graph matching distance [86] with
regard to the application in quantitative workflow evaluation [39]. The authors conclude, “that the
Levenshtein and Adjacency distances are best suited for measurement of distances between the
activity sequences of surgical process models”. Thus, the Levenshtein distance was used for the
similarity evaluation of clinical processes beside surgical interventions. The Levenshtein distance
measure, however, takes into account the minimal number of insert, delete or replace operations to
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convert one string into another one.
dL =

0 if equal
+1 replace
+1 delete
+1 insert
The following example also depicted in Figure 6.8 should clarify the chosen approach. Given two
strings X = ABCDEF with |X| = 6 and Y = ABBCDM with |Y | = 6. To convert string Y
into string X the following procedure could be applied. At first the second B from string Y has
to be removed. Afterwards the M has to be replaced with an E and finally a F has to be added to
string Y . The applied operations are not unique so that there may exist different ways for string
transformation. The Levenshtein distance in this example equals dL = 3 and is calculated as the
minimal number of necessary operations.
1 2 3 4 2 
A B E C D 
A B E C D F 1
A B B MC D 
2
3
String X 
String Y 
Figure 6.8 – Conversion of string X into string Y using Levenshtein algorithm. Numbers denote: 1 –
delete, 2 – replace, 3 – insert
6.6.2 Distance measurement results
The clinical study encompasses 16 anamneses documented within the SAP i.s.h.med free text field
as control group as well as 11 anamneses documented with the structured oncoflow form as study
group. In Table 6.4 the number of documented information entities, the Levenshtein distance for
each anamnesis compared to the ideal sequence of questions, the mean value and the standard
deviation are depicted. The Levenshtein distance of SAP i.s.h.med will be denoted as dLsap and for
oncoflow it will be referred to as dLof .
Mann-Whitney-U tests have been applied to the number of documented information (p = 0.0023)
and the Levenshtein distances (p = 0.0001) which means that the populations show significant
differences. However, the Levenshtein distance without additional knowledge provides no infor-
mation about the real differences between the gold standard and the actually documented amount
of information in the current observation set. Hence, the number of documented data entities has
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Table 6.4 – Levenshtein distances comparing gold standard with anamneses from SAP i.s.h.med and on-
coflow
SAP i.s.h.med oncoflow
Anamneis # data dLsap # data d
L
of
1 1 9 7 5
2 2 8 10 2
3 10 9 11 1
4 5 7 11 2
5 9 6 14 6
6 4 9 10 2
7 11 7 10 0
8 9 6 9 3
9 0 5 10 0
10 0 5 10 0
11 8 4 10 0
12 8 4 - -
13 8 6 - -
14 9 7 - -
15 8 5 - -
16 9 7 - -
Mean 7.44 6.50 10.18 1.91
Std. dev. 2.87 1.67 1.66 2.07
to be considered in the evaluation. The results for the documentation in SAP i.s.h.med show a
mean Levenshtein distance with µ = 6.50, thus, a significant difference to the ideal documentation
workflow. Considering the mean number of documented data entities (µ = 7.44) less information
as defined in the optimal workflow has been documented. The oncoflow results show significant
workflow improvements. The usage of the web-based anamnesis form results in a reduction of the
mean Levenshtein distance by 4.59 to µ = 1.91. The mean number of documented information
entities increased to µ = 10.18 which shows that basically all questions, which are important for
the treatment process, are asked by the physician.
In Figure 6.9 the recorded information and Levenshtein distances are depicted in a boxplot
representation. The boxplots show that the number of datasets increased through the usage of
oncoflow, but also that the standard deviation strongly decreased. Hence, one can see that the
Levenshtein distance shows a high decrease in oncoflow, but the standard deviation is equally high
as in SAP i.s.h.med.
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Figure 6.9 – Boxplot representation of left: # of data elements recorded during the anamnesis; right: Lev-
enshtein distances
6.7 Discussion
The study presented in this paper confirms that a clinical information system developed in close
cooperation with clinicians and tailored to the daily clinical routine is well accepted by the physi-
cians and supports efficiently the clinical workflow. The study also shows that routine tasks that
have been formerly supported by other information systems are not retarded significantly by the
introduction of a new information system. The clinical study focused on anamnesis and clinical
examination. In this process step the physician makes extensive use of the new user interface and
workflow assistance functions during results documentation. However, only anamnesis and clinical
examination with oncoflow is directly comparable to the existing workflow in daily clinical routine
and can serve as an objective quantitative and qualitative evaluation of oncoflow. The time measure-
ment part of the study quantitatively depicts that both approaches for results documentation are not
differing significantly. The respective Table 6.2 and Table 6.3 show especially in the median values
that documentation in oncoflow needs only few more time than the usage of SAP i.s.h.med. Based
on the fact that only few samples exist in each sample population the empirical mean and median
values are less representative. Thus, statistical tests that are tailored to the evaluation of studies with
62
6.8. CONCLUSIONS
small sample sizes have been applied to prove that both observations are not differing significantly.
The equality of both workflow times is important for further usage of the system in daily clinical
routine because it shows that the new system does not impair the efficiency of anamnesis and first
clinical examination.
Furthermore, the complete anamnesis workflow was standardized. Our evaluation using Leven-
shtein distance measure revealed that the physicians follow the standardized set of questions. Hence,
more patient-specific information is recorded within the new system. The number of documented
information entities could be increased from 7.5 questions with SAP to 10 questions in oncoflow.
This is an improvement of 25%.
The results of the questionnaire evaluation show that oncoflow supports the work of the physician
very well in contrast to SAP i.s.h.med. The electronic patient record of oncoflow has been judged as
well-structured; hence, the possibility for quickly accessing relevant information has been improved.
Also the structured report form for results documentation makes this process step more efficient
because the usage of additional supporting word documents is now obsolete and each physician
uses a standardized set of questions that were agreed among all senior physicians. The other set of
questions in the questionnaire addressed the user satisfaction of the physician with SAP i.s.h.med
and oncoflow. Finally, the results show good ratings for oncoflow and low ratings for SAP i.s.h.med,
respectively. The questionnaire evaluation also provides potential for improvements. The small
number of five participating physicians and the usage of oncoflow in only one specific hospital
is not sufficient for strong and objective results. The clinical processes that have been considered
in the time measurement study have not been completely identical. The physicians in the experi-
mental group needed one additional process step as workaround for transferring the documented
information into the HIS. This time frame has been regarded as additional documentation time and
directly compared with the documentation time in SAP i.s.h.med. Future work should focus on the
implementation of a bi-directional communication interface between SAP i.s.h.med and oncoflow
so that this process step is obsolete. Afterwards, this study should be performed again with two
identical workflows. This second study should also include a higher number of workflows as well as
a larger number of participating physicians. The conduction of a study that also includes physicians
and processes from a different hospital would make the results much stronger.
6.8 Conclusions
We developed a comprehensive electronic patient record that automatically imports and restructures
information from existing clinical information systems. The information is centrally available for
the physician via a well-designed web interface and is instantly usable for further electronic process-
ing. Furthermore, the oncoflow system provides different assistance functions such as a Treatment
Summary and the automatic creation of physician letters based on existing patient information. The
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tumor board is an important step in the oncological patient treatment process. All physicians and
surgeons that take part on the patient treatment meet there for discussing possible treatment options
and finding the best therapy. The oncoflow system together with the TPU provides extensive support
for the tumor board. The system supports the creation of invitation letters, tumor board protocols,
enriches the board discussion with endoscopic images and 3d tumor reconstructions and provides
a voting system to make the decision making process more transparent. Within a clinical study
that focused on the user acceptance of a completely redesigned electronic patient record and the
usefulness of assistance features supporting daily clinical routine the new information system has
been evaluated.
A time measurement study has been conducted to evaluate if the usage of the new system
influences the time needed for conducting an anamnesis and clinical examination. This study
showed that the overall time needed with the new information system is only 8.4% slower in
the mean value and actually 0.3% faster with regard to the median value. A questionnaire-based
evaluation study focused on the evaluation of the process improvement and user acceptance of the
new system. The results show that physicians appreciated the new assistance functions and find
information faster in the new electronic patient record. The new user interface received very good
ratings and all physicians could imagine using the system furthermore in daily clinical routine.
Standardized and transparent workflows are important for the certification as cancer center, out-
come documentation and quality management, and finally for evidence based medicine. Due to the
usage of a structured documentation form physicians perform an anamnesis whose structure could
be improved by 71%.
Due to the promising results future work will focus on the establishment of systematic and
patient-oriented tumor documentation. Follow-up results are especially important for the evaluation
of previous tumor therapies. Thus, standardizations in this area seem to be very fruitful.
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Chapter 7
Workflow recognition
7.1 Motivation
The substantial amount of patient-specific information in clinical information systems helps physi-
cians and surgeons obtain increasingly comprehensive overviews of patients. This information is
available but is insufficiently structured and poorly searchable, particularly in the large HISs such
as SAP i.s.h.med. There are several reasons for the poor structuring of this information, but it is
mainly due to the primary economy-driven documentation goals of hospitals. Mature IT solutions
are still lacking for a primary focus on treatment decision making, for hierarchically organizing
patient-specific results, and for summarizing the results of relevant pretreatment investigations. This
situation leads to inefficient processes in daily clinical routine and to considerable time spent search-
ing documents that are relevant in the current treatment phase. Unfortunately, physicians do not
have the ability to simply and quickly obtain the most relevant documents for the specific therapy
phase. Furthermore, scientific questions such as “Show me all of the clinical documents that are
generated during surgical interventions for patients with laryngeal carcinoma” cannot readily be
answered using the currently available clinical information systems.
To improve clinical workflows, to relieve physicians and surgeons from time-consuming activi-
ties, to improve patient safety and to reduce costs, developing user-friendly and intuitive capabilities
for searching and accessing clinical data is of critical importance. A fundamental prerequisite is
knowledge of treatment processes in general, as well as specific knowledge regarding the current
treatment phase of the patient. Knowledge of the overall treatment process can be acquired through
a workflow analysis in the specific clinical disciplines or departments. Statistical models such as
Hidden Markov Models (HMMs) are good methods for subsequently transferring the workflow
analysis results into a mathematical representation that can subsequently be used to infer workflow
phases from given patient-specific information that originates from clinical information systems,
i.e., the so-called observations [36].
In this work, a completely new approach for automatically inferring the current step of a clinical
patient treatment process from clinical data is presented. First, patient-specific information from
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different clinical information systems is used as training data for creating a probabilistic model
of the underlying treatment process. Subsequently, patient-specific information that was not a
part of the training process can be provided to the model for predicting the most likely treatment
step. Finally, each patient-specific information entity, such as disease codes, procedure codes or
laboratory results, contains additional meta-information regarding the originating process step.
This meta-information is very valuable for the development of sophisticated workflow assistance
or clinical decision support systems.
Additionally, a mathematical representation of clinical workflows provides an important basis
for a wide variety of analyzes. The model can identify both the most likely course of treatment as
well as outliers for patients with complex cases. Subsequently, this information provides the basis
for improving clinical pathways or for serving as a metric for clinical quality management [87].
7.2 Goals of this work
The primary objective of this work is to develop a new method for predicting single phases of
the oncological treatment process based on patient-specific information entities originating from
clinical information systems. The first step is to develop a probabilistic model based on HMM that is
able to represent clinical workflows in different granularity levels. This model should then be able to
predict the current treatment phase for a set of unknown clinical patient-specific information entities.
We developed two types of HMM models with 3 and 7 therapy phases and with additional exception-
handling approaches to address different types of variations in clinical workflows. The exception-
handling approaches consider both the hierarchical properties of ICD10 and ICPM codes, as well
as others, to improve the HMM prediction rates. These models are then trained with anonymized
real-world clinical datasets from patients with primary head and neck tumor diagnoses. Finally,
two types of HMM models are evaluated in terms of their recognition rates and the results of their
exception-handling algorithms.
7.3 Theoretical background
Statistical models such as HMMs provide the theoretical basis for a wide range of applications
and are also appropriate for modeling clinical workflows [88, 89, 90, 91]. Hence, this section will
provide a brief introduction to HMMs and the algorithms used in this work.
We first wish to briefly discuss why we decided to use HMMs and to compare HMMs to neu-
ral networks and decision trees [92, 93]. The HMMs is a well-established method for workflow
recognition with proven mathematical foundations. Additionally, many studies have previously em-
ployed HMMs for the recognition of surgical workflows, as depicted in detail in Section 2.4, with
promising results. In our case, HMMs provide several advantages compared to neural networks
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and decision trees. First, a substantial amount of training data is required to train neural networks.
Furthermore, neural networks do not operate on transition and observation probability matrices,
which is an important feature of HMMs. These matrices provide transition and observation prob-
abilities in human-readable form, which provides a basis for further research, such as analysis of
clinical workflows. Decision trees are a method for rule-based classifications: Each node in the tree
represents one rule. Following the tree from the root node to the leaves, it provides exactly one
answer to a specific question. The disadvantages of decision trees include their size when rules
are very complex and their relatively low recognition rates compared to other algorithms [94, 95].
Finally, we decided to use a HMM in this case, but we will eventually perform the study with other
algorithms in the future to compare the results.
7.3.1 Hidden Markov Model
A HMM describes a process over time. This process is characterized by a sequence of states that
change by chance. The state change is modeled with a random variable Xt, where the transition
probability between the states only depends on the current state, not on the past states. This property
is called the “memorylessness” or Markov property. The states are not directly observable in a HMM
because they are hidden, but each state yields so-called observations that are used for inferring the
most probable state at time t. Observations can also be described with a random variable Yt. A
HMM is a 5-tuple λ = (S;M ;A;B; pi), where:
• S = {s1; . . . ; sn} Number of hidden states and values of Xt
• M = {m1; . . . ;mm} Number of possible observations and values of Yt
• A ∈ Rn×n Transition matrix; ai,j denotes the probability of changing from state i to state j
• B ∈ Rn×m Observation matrix; bi,j denotes the probability of observing mj in state si
• pi ∈ Rn Initial state distribution; pii = P (X1 = si) denotes the probability that si is the initial
state.
7.3.2 Viterbi algorithm
To find the most likely state sequence Q = {q1; . . . ; qT} ∈ S for a given HMM λ and observation
sequence O = {o1; . . . ; oT} ∈ M , the Viterbi algorithm can be used [96]. The Viterbi algorithm
incorporates the transition and observation probabilities of individual states as well as the proba-
bilities previously calculated for all states t− 1. This makes the Viterbi algorithm more robust to
zero probabilities (ai,j = 0 for some i and j) [36]. However, lacking probabilities in the underlying
model may lead to serious problems. Two approaches for solving these drawbacks are presented in
Section 7.4.3.
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7.4 Materials and methods
7.4.1 Data acquisition
Integration of patient information
Clinical information is not stored within a central database but is rather distributed across multiple
information systems, such as HIS, Radiology Information System (RIS), PACS or research-driven
department-internal solutions [7]. This leads to inefficient clinical workflows and hinders the exe-
cution of clinical studies due to the lack of patient-specific information and error-prone copy-paste
procedures. To mitigate the aforementioned drawbacks, a web-based clinical information system,
oncoflow, has been developed [72]. The oncoflow system has been tailored to support physicians
and surgeons in daily clinical routine during the treatment of patients with head and neck carcinoma.
Therefore, electronic communication interfaces have been developed to import therapy-related in-
formation into a central database (see Figure 3.3). There are two main information sources, the
HIS and the DTTM, that provide the majority of relevant patient-specific information. The first con-
sultation reveals important therapy-related details, such as personal habits like alcohol or nicotine
consumption, comedication or former surgical interventions. This information is acquired using a
structured web-based documentation form. Finally, a broad set of information is acquired during
follow-up consultations through the use of an Android tablet-based screening tool for functional
disorders [60, 61].
Physicians and surgeons at the Leipzig University Medical Center have used the oncoflow system
in daily clinical routine as a scientific prototype since March 2013. To train the HMM, only an EPR
that contains at least a first consultation, a panendoscopy, a tumor board and a follow-up dataset
is used to ensure that the patient already underwent the entire treatment process. Available tumor
therapy-related ICD10 and ICPM datasets serve as important training data for the HMM.
Data selection, export and processing
The patient-specific information in the oncoflow database is not instantly usable as training data for
the HMMs. Hence, an appropriate EPR must be identified, after which relevant information entities
can be extracted. First, the patient datasets, which contain at least one entity of consultation, pa-
nendoscopy, tumor board and follow-up, were identified in the database. The resulting 40 available
EPRs that met the required criteria provided the basis for creating the HMMs. Subsequently, the
previously mentioned information entities and the tumor therapy-related ICD10 and ICPM codes
from the specific patients were selected and exported in chronological order as a Comma-Separated
Values (CSV) file, which serves as the input for the HMM. Detailed numbers are presented in Table
7.1. An information entity is also referred to as an observation.
The ICD10 and ICPM codes provide a hierarchical mapping of health conditions or operation
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Table 7.1 – Distribution of observations in the selected EPRs.
total # of
EPRs
total # of
observations
average # of
observations per EPR
minimum # of
observations per EPR
maximum # of
observations per EPR
40 2208 55 19 100
procedures to generic categories. To reduce the complexity of the HMMs and to increase the hidden
state recognition rate, two different approaches are evaluated in this paper. The first approach is
to construct the HMMs with full ICD10 and ICPM codes, which results in a more complex model
with a larger number of observations. The second approach is to reduce the depth in the hierarchy
by shortening the ICD10 and ICPM codes to a coarse granularity.
In the following examples, the ICD10 code C32 and the ICPM code 5-303 should clarify the
procedure. C32 denotes a malignant tumor in the larynx and can be viewed as a parent node in
the ICD10 classification. In the selected EPRs, more specific descriptions of this disease are used,
such as C32.0, which denotes a malignant tumor in the glottis, or C32.3, which denotes a malignant
tumor in the cartilage of the larynx. The same holds for the ICPM code 5-303, which encodes a
laryngectomy. In more fine-granular representations, 5-303.0 denotes a simple laryngectomy, and
5-303.01 denotes a reconstruction with local mucosa.
To evaluate the influence of the aforementioned code lengths on the prediction results, a post-
processing of the exported information was performed. Therefore, all of the ICD10 and ICPM
codes were shortened to their hierarchical parents and stored in a second CSV file for later use.
Using the shortened disease and procedure codes results in fewer observations and more robust
transition probabilities in the HMM.
7.4.2 Model properties
The oncological treatment process can be represented by different levels of granularity. At the finest-
grained level, the process can be characterized by information entities in the EPR, such as ICD10
or ICPM codes. Unfortunately, this information is not readily usable by physicians or surgeons
for obtaining a quick overview on the current medical status of the patient or for identifying the
relevant information entities in the current treatment step. Hence, a presentation of the process in
an adjustable granularity must be developed for the specific clinical or organizational needs.
In this study, two types of HMMs with different numbers of hidden states were developed in close
cooperation with physicians and surgeons from the local head and neck department (see Figure 7.1).
The 3-state model is a coarse representation of the workflow as described in Section 1.2 and allows
existing patient data to be divided into three different categories. The finer-grained 7-state model
is actually more helpful for physicians in daily clinical routine because the current treatment steps,
such as panendoscopy or therapy, are clearly identifiable and existing patient data from the current
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step can be acquired instantly.
To train the HMM, each of the 2208 observations were manually tagged with the correct state
for the 3-state model and for the 7-state model. The appropriate states for the specific observations
were identified by studying the specific EPRs in the HIS and receiving support from physicians and
surgeons to clarify observations in which the actual state was not clearly identifiable. Finally, four
CSV files were created for generating the HMM:
• 3-state model with full ICD10/ICPM codes
• 3-state model with short ICD10/ICPM codes
• 7-state model with full ICD10/ICPM codes
• 7-state model with short ICD10/ICPM codes
Based on the tagged observations, the initial state distribution pi, the transition probability matrix
A and the observation matrix B can be created. The length of the initial state distribution vector
pi ∈ Rn is equal to the number of hidden states of the HMM. For each data set included in the
model, the hidden state of the first observation is assigned to the vector element of this hidden state
in pi. Finally, the initial state distribution is calculated. The transition matrix A ∈ Rn×n, where n
denotes the number of states, is generated by assigning each state transition to the corresponding
element in the matrix. If no state transition occurs from the observation at time t to the observation
at time t + 1, then the matrix element Aj,j , where j denotes the current state, is increased by 1.
Let n be the number of states and m be the number of observations; then, the observation matrix
is given by B ∈ Rn×m. The matrix is generated by assigning each observation and its hidden
state to the corresponding matrix element. The final probability distributions for A and B are row
Oncological Treatment Process 
Clinical Diagnostics 
Anamnesis Panendo- 
scopy 
Tumor Board 
Therapy 
Surgical 
Intervention 
Radiochemo 
Therapy 
Follow-
up 
Follow-up 
Workﬂow-­‐independent	  therapeu2c	  ac2vity	  (e.g.	  nutri2onal	  consul2ng) 
Figure 7.1 – Oncological treatment process in different granularity levels for patients with head and neck
carcinoma. In the scope of this work, each step represents a hidden state in the HMM.
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stochastic and calculated for each row in the matrix such that
∑n
j=1A[i, j] = 1 ∀i ∈ {1 . . . n} and∑m
j=1B[i, j] = 1 ∀i ∈ {1 . . . n} hold.
7.4.3 HMM exception handling
Exception sources
Statistical models such as HMMs are based on probability distributions for predicting hidden states
from given observations. Thus, specific observations may be misclassified or not classified at all due
to missing transitions or observation probabilities. The exception handling presented in this section
focuses on observations that are not classified by the HMMs and are thus tagged as unclassified
(see Figure 7.2). There are two reasons why observations may not be classified.
The first reason is that a specific observation is only present in one EPR. Hence, when this patient
record serves as test object during the leave-one-out cross validation, the specific observations are
not included in the HMM generation, the respective elements in the B matrix have zero probabil-
ity, and the model fails during the study. This situation is mitigated beforehand, and the specific
observations are tagged as unclassified. A detailed description is given in Section 7.4.3.
Unfortunately, the classification with the Viterbi algorithm also fails in the case of specific
observation sequences in which transition and observation probabilities are given. This case occurs
when the study observation sequence significantly differs from the observation sequences used to
generate the model. The respective observations are also tagged as unclassified.
To improve the overall recognition rates of the HMMs, two algorithms for exception handling
were developed. The algorithms are applied to the state sequence produced by the Viterbi algorithm
and aim to identify and re-classify the existing unclassified observations.
1 2 3 4 2 
A B E C D 
Figure 7.2 – Exemplary state sequence as a result of the Viterbi algorithm applied to the observation
sequence A–E. States 1–3 are classified by the HMM. State 4 denotes unclassified and will
subsequently be treated by the exception-handling process.
Previous recognized state
The first exception-handling algorithm sequentially parses a given state sequence for unclassified
states and remembers the last classified state. If an unclassified state is found, it is assumed that
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the model is still in the same state as predicted for the previous observation, and the previous state
is assigned to the actual observation. This approach has two major drawbacks: the first is that this
algorithm is not applicable if the first observation is already unclassified - in this case, the first and
all immediately following unclassified observations remain unchanged. The second drawback is
that this approach can only be applied to models in which consecutive states are equal for a certain
number of observations. If the hidden states change frequently in consecutive observations, this
approach may yield poor outcomes.
Observation-specific State Estimation
The Observation-specific State Estimation (OSE) approach is more sophisticated and aims to over-
come the drawbacks of the previous recognized state algorithm described in Section 7.4.3. OSE
incorporates knowledge about the hierarchical structure of ICD10 and ICPM codes in combination
with modified parts of standard HMM algorithms to finally acquire hidden states for observations in
which the standard HMM failed. The input parameters for OSE are the state sequence produced by
the HMM’s Viterbi algorithm ~νViterbi, the corresponding observation sequence ~ω and the underlying
HMM, including the A,B and pi matrices; the set of hidden states S; and the set of observations M
(see Algorithm 1).
Initially, the given sequence of resulting states ~νViterbi is sequentially parsed to locate unclassified
states (see Algorithm 1; line 1). If an unclassified state νi is found, the corresponding observation
ωi is acquired from the observation sequence. To find the most probable state for ωi, the OSE
algorithm is applied to all states s in the actual model (see Algorithm 1; line 7). Then, two different
cases must be distinguished. In the first case, the current observation is part of the HMM, which
means that this observation was part of the learning process of the model and has transition and state
probabilities in the corresponding matrices. Hence, these probabilities can be immediately used
to calculate the highest state probability (see Algorithm 3). In the second case, the observation is
not part of the model training; hence, there are no transition and observation probabilities available.
Thus, in the case that the observation is an ICD10 or ICPM code, similar observations are searched
within all available observations M (see Algorithm 2), and the highest state probability for these
observations can be subsequently computed (see Algorithm 1; lines 11, 12). Subsequently, the
highest probability and the corresponding state are updated.
However, there is still a possibility that no appropriate similar observations can be found, and
thus, the hidden state remains unclassified. In this case, the previous recognized state is selected as
the fallback solution, as depicted in Section 7.4.3 (see Algorithm 1; lines 19, 20). Finally, the state
of the current observation is updated.
Algorithm 2 shows the procedure for finding observations that are similar to a given observation.
Here, the hierarchical structure of ICD10 and ICPM codes is utilized. First, a regular expression
is used to ensure that the given observation ωi is an ICD10 or ICPM code (see Algorithm 2; line
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Algorithm 1 The Observation-specific State Estimation (OSE)
input: observation sequence ~ω, Viterbi result sequence ~νViterbi, HMM λ
1: for each νi ∈ ~νViterbi | νi = unclassified do
2: highestProbability = 0
3: mostProbableState = unclassified
4: observation ωi = ~ω[index(νi)]
5: HiddenStates S = λ.S // get list of hidden states from HMM
6:
7: for each s ∈ S do
8: if ωi ∈ λ then
9: _prob = calculateHighestStateProbability(ωi, s, λ)
10: else
11: _simObs = findSimilarObservations(ωi)
12: _prob = calculateHighestStateProbability(_simObs, s, λ)
13:
14: if _prob > highestProbability then
15: highestProbability = _prob
16: mostProbableState = s
17:
18: // fallback solution
19: if highestProbability = 0 then
20: mostProbableState = usePreviousRecognizedState()
21:
22: νi = mostProbableState
3). Then, a search string is created from the observation. During each iteration in the while-loop,
the search string is shortened by one character, which means that the resulting string matches a
wider set of ICD10 or ICPM codes, as described in detail in Section 7.4.1. Subsequently, the current
search string is compared to all observations in the given HMM. When the search string matches a
given observation code for the first time (longest prefix match), the corresponding code is saved in
an array Θ, and the while-loop is stopped for the next iteration (see Algorithm 2; lines 11-13). The
for-loop processes the remaining observations in M such that the most similar observations may
be found.
Algorithm 3 aims to find the highest probability for observation ωi being in state s at time t.
Therefore, the transition probabilities from all states k ∈ S at time t − 1 into state s at time t are
multiplied by the probability of the observation being in state s. This procedure is performed for all
observations Θ, and finally, the highest probability is returned. Unlike the forward variables αt(i)
in [36], the HMM model probabilities for being in state k at time t−1 are not included in the actual
calculation to avoid the influences of any incorrect calculations from the Viterbi algorithm.
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Algorithm 2 findSimilarObservations
input: observation ωi, hidden state s, current HMM λ
output: array of observations Θ
1: Observations M = λ.M\ωi // get list of observations from HMM w/o ωi
2:
3: if (ω ∈ ICD10) or (ω ∈ ICPM) then
4:
5: found = false
6: searchString = ωi
7: while searchString.length > 1 and ! found do
8: searchString.removeLastCharacter
9:
10: for each m ∈M do
11: if m.startsWith(searchString) then
12: Θ.add(m)
13: found = true
14:
15: return Θ
Algorithm 3 calculateHighestStateProbability
input: array of observations Θ, hidden state s, HMM λ
output: probability for being in state s
1: TransitionMatrix A = λ.A // get transition matrix from HMM
2: ObservationMatrix B = λ.B // get observation matrix from HMM
3: HiddenStates S = λ.S // get list of hidden states from HMM
4: highestProbability = 0
5:
6: for each θ ∈ Θ do
7: observationProbability = B[s][θ]
8:
9: for each hidden state k ∈ S do
10: transitionProbability = A[k][s]
11: currentProbability = observationProbability ∗ transitionProbability
12:
13: if currentProbability > highestProbability then
14: highestProbability = currentProbability
15:
16: return highestProbability
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7.5 Case study
7.5.1 Software design
To apply a HMM to a given observation sequence for predicting the corresponding sequence of hid-
den states, additional mathematical algorithms, such as the Viterbi algorithm (see Section 7.3.2), are
necessary. Therefore, the open source software library jahmm (https://code.google.com/p/jahmm/)
was used. This library implements the basic Forward and Viterbi HMM algorithms as well as the
Baum-Welch and K-Means structure learning algorithms. A Java-based command line applica-
tion was developed to implement the model generation process (see Section 7.4.2), to include the
jahmm library and to perform the HMM exception handling (see Section 7.4.3. The software also
performs the statistical calculations presented in Section 7.6.
7.5.2 Study execution
The aforementioned theoretical approaches for HMM model generation, hidden state prediction
and exception handling were conducted in an evaluation study. The study was performed with a
command line Java application (see Section 7.5.1) and four CSV files containing the input obser-
vations and the corresponding hidden states (see Section 7.4.2). Each input file contained N = 40
EPRs with the specific observations in exactly the same order but in a different granularity or as a
different model type (3-state or 7-state).
To estimate the accuracy of the HMM and the presented exception-handling methods, the leave-
one-out cross validation technique was used [97]. This approach uses N − 1 observation sequences
and the corresponding hidden states (known data) as a training data set. The N th observation
sequence serves as an independent validation sample (unknown data) against which the model is
tested. Hence, the study must be performed N times for each CSV input file. Within each iteration,
one HMM is generated with the training data and then tested against the left-out observation
sequence.
However, some observations are only included in one EPR. These observations are presented
in detail in Section 7.6.1. This leads to significant problems during the execution of the study if
the specific EPR serves as the validation data set. In this case, the lacking probabilities in the
transition and observation matrices cause the Viterbi algorithm to yield incorrect state prediction
results. To mitigate these shortcomings, the validation observation sequence is checked prior to
the Viterbi processing. Therefore, each observation of the validation sample is checked against
all observations included in the HMM, which are processed during training of the model. If the
validation sequence contains such singular observations, the corresponding index is stored and the
observation is removed from the original test sequence. Subsequently, the test sequence serves as
an input for the Viterbi algorithm such that the processing can be finished without failure. Then, the
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resulting state sequence is restored to the length of the original observation sequence by inserting
the state unclassified at the index positions of the previously removed observations. The resulting
state sequence then immediately serves as input data for exception handling or can be used directly
for postprocessing.
The resulting state sequences of each iteration are stored for later postprocessing. After postpro-
cessing, the results are compared to the states of the previously tagged observations, and both the
correct and incorrect predicted states are counted in different granularities, including for each itera-
tion, for each hidden state and for the entire cross validation. The recognition rates are subsequently
calculated. The results are depicted in detail in Section 7.6.
7.6 Results
7.6.1 Model recognition rates
Table 7.2 presents the recognition rates of the Viterbi algorithm without any exception handling.
The median values of 86.3% and 86.6% for long ICD10 and ICPM codes (in contrast to 89.6% for
short codes) show that the pure HMM is more sensitive to the code length than to the number of
hidden states. The minimum recognition rates for long codes are lower than those for short codes.
One can also observe that the recognition of at least one observation sequence in the 7-state HMM
completely failed because the minimum recognition rate is 0%. This also leads to a significantly
higher standard deviation in the 7-state model with long codes.
Table 7.2 – State recognition results for the use of a pure HMM without exception handling. All values are
depicted in %.
3-State-Model 7-State-Model
long codes short codes long codes short codes
Recognition rate 85.37 88.54 82.20 87.14
Minimum 60.00 64.94 0.00 63.64
Maximum 96.83 100.00 97.50 100.00
Median 86.32 89.66 86.59 89.58
Std. deviation 8.89 7.69 16.45 9.04
The first applied exception-handling algorithm that uses the last known state improves the recog-
nition rates in all model types (see Table 7.3). In particular, the median value increased to 90% for
each type, which thus indicates that the dependency on the length of the underlying ICD10 and
ICPM codes could be mitigated. The minimum recognition rates increased significantly from 7%
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to 10%. Unfortunately, this exception-handling approach is unable to correct observation sequences
that are completely unclassified; therefore, the minimum recognition rate of the 7-state model with
long codes is still 0%. The average and maximum recognition rates are slightly increased, and the
standard deviation shows a slight decrease, except for the 7-state model with long codes.
Table 7.3 – State recognition results for the use of a HMM with additional exception handling. In this case,
the last known state is used for observations with no state assigned by the plain HMM. All
values are depicted in %.
3-State-Model 7-State-Model
long codes short codes long codes short codes
Recognition rate 89.31 90.35 85.78 88.72
Minimum 70.00 75.00 0.00 70.21
Maximum 100.00 100.00 98.08 100.00
Median 89.53 90.62 90.05 90.77
Std. deviation 6.75 6.13 16.15 7.68
The results for the OSE approach are presented in Table 7.4. The overall, median and maximum
recognition rates are actually quite similar to those of the previous state exception-handling ap-
proach. A major improvement is the increase in the minimum recognition rate of the 7-state model
with long codes from 0% to 66.7% and a decrease in the standard deviation from 16% to 8.6%. This
result indicates that the OSE approach is able to correct hidden states of observation sequences
even if the Viterbi algorithm completely fails.
Table 7.4 – State recognition results for the use of a HMM with additional exception handling. In this case,
an observation-specific state estimation algorithm is used for the recognition of observations
with no state assigned by the plain HMM. All values are depicted in %.
3-State-Model 7-State-Model
long codes short codes long codes short codes
Recognition rate 88.99 90.31 86.78 88.81
Minimum 63.33 73.33 66.67 70.21
Maximum 100.00 100.00 98.28 100.00
Median 89.83 90.62 89.54 90.40
Std. deviation 7.52 6.34 8.65 7.76
Finally, in Table 7.5, the number of states that were corrected by the previous state and the OSE
exception-handling algorithm are presented. This table shows that both algorithms handled the
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same number of unclassified observations. Furthermore, it can be observed that the OSE approach
failed for eight specific observations, which are characterized by the following six ICD10 codes:
L02.1 (skin cheek abscess), K44.9 (Hernia diaphragmatica), C43.0 (malignant lip malignoma),
C64 (malignant renal tumor), F33.2 (depressive dysfunction) and B37.81 (Candida oesophagitis).
Within all 2208 observations, the observation L02.1 was present three times in one EPR, and the
other observations were present only one time. For these observations, the OSE algorithm could
not find similar observations, and thus, the fallback solution was chosen.
Table 7.5 – Number of observations handled by error-correction algorithms.
3-State-Model 7-State-Model
long codes short codes long codes short codes
Previous state ex-
ception handling
110 49 140 49
OSE classifica-
tion
102 41 132 41
Previous state fall-
back for OSE
8 8 8 8
7.6.2 Model accuracy
In this section, the results regarding the model accuracy are shown, which means that the recognition
rates differed according to the hidden states in the HMM.
Table 7.6 presents the recognition rates for the 3-state model grouped by the different code lengths
and exception-handling mechanisms. As shown, the recognition rates are equally distributed for the
diagnostic and therapy phases. The recognition rates during the follow-up phase range between 3%
and 7% lower. However, although there is no significant difference between the percentage values,
there is no model-phase combination in which the recognition rate reaches 100%.
The result from the therapy-phase based evaluation for the 7-state model is presented in Table
7.7. The results for the anamnesis, panendoscopy and follow-up phases are homogeneous within
the same ICD10 and ICPM code length but show better results for short codes. The tumor board
and radiochemotherapy states show high recognition rates for each model type, in which the tumor
board state yields recognition rates up to 100%. Finally, the recognition rates for the intervention
and the other care phases are less than those of the aforementioned phases. These findings are
discussed in detail in Section 7.7, in which the connection to the specific observation in these
phases is established.
78
7.6. RESULTS
Table 7.6 – Hidden state-centered view of the recognition rates for the different 3-states model therapy
phases. All values are given in %.
observation type long observations short observations
exception handling w/o last state OSE w/o last state OSE
Diagnostic phase 87.30 89.42 88.15 89.56 90.13 89.70
Therapy phase 85.38 90.86 90.70 88.62 91.53 91.61
Follow-up phase 80.68 82.71 84.07 85.76 86.10 86.44
Table 7.7 – Hidden state-centered view of the recognition rates for the different 7-states model therapy
phases. All vales are given in %.
observation type long observations short observations
exception handling w/o last state OSE w/o last state OSE
Anamnesis 82.02 85.39 84.27 89.89 91.01 89.89
Panendoscopy 83.14 85.01 85.71 86.18 86.42 86.18
Tumor board 95.74 95.74 100.00 100.00 100.00 100.00
Radiochemotherapy 89.49 93.09 92.69 91.62 93.75 94.02
Intervention 69.03 81.86 87.17 78.76 84.51 84.96
Follow-up 79.24 81.31 83.39 88.93 89.27 89.62
Other care 75.13 76.72 77.51 80.69 81.48 81.48
7.6.3 Model comparison
The study results are presented in side-by-side boxplots in Figure 7.3. Each plot shows a single
HMM type, the corresponding recognition rates for the plain Viterbi algorithm and the exception-
handling approaches. In general, all of the plots show quite similar recognition rates for the different
model types and exception-handling approaches (as previously discussed in detail in Section 7.6.1).
Comparing the interquartile ranges reveals that the spread of the 7-state model results is consid-
erably greater than that of the 3-state model. The median value in the 3-state model is situated in
the center of the boxplot and exhibits a symmetric probability distribution. In contrast, the median
value in the 7-state model is situated at the top of the box, which shows a high skewness or asym-
metric probability distribution. Regarding the interquartile ranges between the long and short codes,
plot A and plot B do not show significant differences, which indicates that the algorithms perform
identically for the 3-state model regardless of the code length. The interquartile ranges in plot C
and plot D show a considerably larger difference, which leads to the conclusion that the code length
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plays a larger role when the model consists of more states.
Finally, the outliers in the boxplot provide important information about the different algorithms.
The 3-state model in plot A and plot B show the most outliers for the plain HMM. Plot A shows
additional outliers for the exception-handling algorithms, whereas the 7-state model shows less
outliers for the model with long codes in plot C. This plot also shows the two observation sequences
that are completely misclassified by the plain HMM but corrected by the OSE approach. The 7-state
model with short codes in plot D shows more outliers for all model types.
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Figure 7.3 – Boxplots of the HMM recognition rates.
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7.6.4 Correlation between observations and states
The recognition rates of the HMM significantly differ for different hidden states, particularly in
the 7-state model (see Section 7.6.2). To explain the reasons for these differences, two overfitted
HMMs with short observation codes, including all observation sequences, were created for the 3-
state and 7-state models. In general, there are two different types of observations: the first type can
be uniquely identified by the HMM; therefore, this observation only occurs within one hidden state.
The second observation type consists of observations that occur along the entire treatment process
and are present in multiple hidden states. To create an appropriate example, ten representative
observations and their observation probabilities in the B matrix were chosen and transformed into
levelplot diagrams. For comparison, the same observations for the 3-state model and the 7-state
model were chosen and are explained in detail in Table 7.8.
Figure 7.4 shows the levelplot for the 3-state model observation matrix. The observations A–
E are clearly assigned to the clinical diagnostics phase. These are the anamnesis, panendoscopy
and tumor board observations that only appear in this phase. In addition to these clearly allocable
observations, the following observations, F and G, were chosen. These observations are ICD10
codes, which are encoded every time a patient enters a clinical department throughout the entire
treatment process. Thus, these observations are equally distributed across all treatment phases.
Subsequently, observation H denotes a surgical intervention where neck lymph nodes are removed.
This ICPM code primarily appears in the therapy phase, but it also appears in the diagnostics
phase because lymph nodes are sometimes also removed during a panendoscopy. Observation I
represents a radiation therapy that is only conducted during the therapy phase. Finally, observation
J corresponds to a follow-up meeting, which is typically only performed in the follow-up phase;
however, if recidivisms occur directly in the first meeting, the therapy phase is prolonged until the
patient is tumor-free.
The levelplot in Figure 7.5 shows both the states and corresponding observations for the 7-state
model. Only the differences between this model and the 3-state model should be mentioned here.
Observations A–E are separated into 3 different states but are only present in exactly one state.
Observations F and G are present in all states but not in the tumor board state because physicians
and surgeons do not encode ICD10 codes when the tumor board discusses a patient. Due to the
more fine-grained tagging in the 7-state model, observations H and J are only present in one state.
Observation I is again only present in one state, which in this case is a radiochemotherapy state.
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Figure 7.4 – Heatmap of the 3-State HMM observation matrix with selected observations. The map depicts
the probability that an observation will occur in a specific state. For a detailed explanation of
observations A–J, see Table 7.8
7−State HMM Observation Matrix
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Figure 7.5 – Heatmap of the 7-State HMM observation matrix with selected observations. The map depicts
the probability that an observation will occur in a specific state. For a detailed explanation of
observations A–J, see Table 7.8
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Table 7.8 – Detailed explanation of selected observations in the heatmap representation of 3-state and
7-state observation matrices (see Figures 7.4, 7.5).
Observation Acronym Description
A anamnesis An anamnesis observation occurs when the first anamnesis was docu-
mented with the structured report form in oncoflow.
B panendoscopy The panendo observation occurs when a surgeon uses the DTTM for
OR documentation and uploads the results to oncoflow.
C 1-610 This ICPM code denotes a diagnostic laryngoscopy and is assigned
by the surgeon after a panendoscopy.
D 1-630 This ICPM code denotes diagnostic esophagoscopy and is assigned
by the surgeon after a panendoscopy.
E tumor board The tumor board observation occurs when a patient is scheduled for
a tumor board with the oncoflow tumor board assistance module.
F C77 The ICD10 code C77 classifies a secondary malignant tumor in the
lymph nodes.
G C32 This ICD10 code specifies a secondary malignant tumor in the larynx.
H 5-403 This ICPM code denotes a surgical intervention to remove lymph
neck nodes (neck dissection)
I 8-522 This ICPM code specifies a high-voltage radiation therapy.
J follow-up This observation occurs when follow-up information is acquired with
the tablet-based questionnaire system or directly entered in the spe-
cific oncoflow documentation form.
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7.7 Discussion
This work presented a new methodology for predicting clinical workflow steps based on HMMs.
The concepts and algorithms were developed and evaluated in a study with anonymized real-world
patient data sets of 40 EPRs and a total number of 2208 observations. The performed study provided
good results for the recognition of the patient’s current therapy phase based on given observation
sequences. The achieved recognition rates ranged between 82% and 90%.
Pros: The prediction results of a pure HMM’s Viterbi algorithm primarily depend on the lengths
of the used ICD10 and ICPM codes. The number of hidden states in the model does not exhibit
a significant influence on the results. The developed exception-handling approaches improve the
recognition rates and most notably minimize the influence of long and shortened ICD10 and ICPM
codes. Both exception-handling results provide similar outcomes, as shown in Table 7.3 and Table
7.4. The previous recognized state algorithm uses a type of educated guess in combination with the
hypothesis that the actual state of the process does not frequently change over time. In contrast, the
OSE algorithm uses actual transition and observation probabilities from the current HMM along
with knowledge of the hierarchical structures of ICD10 and ICPM codes to estimate the correct
hidden state. Hence, this approach provides higher reliability and robustness; therefore, the OSE
algorithm should be preferred over the previous recognized state algorithm.
The influence of an increasing number of hidden states on the recognition rates is an important
factor for use in cases where the underlying workflows have variable granularity. Fortunately, the
results of this study show that the recognition rates between a model with three states and a model
with seven states do not exhibit considerable differences. Hence, this approach can be used in
scenarios or use cases where models with a highly variable number of hidden states are necessary.
The lengths of ICD10 and ICPM codes were also a subject of the evaluation study. In fact, the
results of the study demonstrated that the hierarchical depth of the underlying codes primarily
influences the recognition rates of the Viterbi algorithm. This behavior is reasonable given the
model complexity. The model with long codes consisted of 185 observations, whereas the model
with short codes consisted of only 117 observations. A smaller number of states results in a smaller
observation matrix, higher probabilities for each observation and thus better prediction results. The
use of exception-handling algorithms improves the recognition rates and increases the robustness of
the model. The OSE approach incorporates the previous findings and reduces the model complexity
by shortening the codes from unclassified observations. Thus, OSE makes the model less complex
to find appropriate transition and observation probabilities.
Cons: However, although the number of observations used in the study is quite large, specific
aspects in the results show that a larger number of observations would have made the model more
robust against complex treatment processes. The outliers in Figure 7.3 plot C can be viewed as an
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example for such an observation sequence originating from a rare complex medical case. A larger
set of training data with a wider variety of treatment processes would result in models that are better
fitted to cluttered workflows and thus provide better recognition results and a decreased need for
exception handling.
Some remarks on the OSE algorithm are also necessary. Observations that are not ICD10 or
ICPM codes can only be corrected by OSE when transition and observation probabilities are
available in the corresponding matrices. A search for similar observations is not currently possible.
Hence, if no probabilities are given for these observations, the last known hidden state is assigned.
The search for similar ICD10 and ICPM codes works very well for the oncological therapy process
in head and neck surgery. However, this approach cannot be immediately applied to treatment
processes in other clinical disciplines. In different medical fields, a broader range of codes may be
encoded such that supposedly similar observations actually yield an incorrect hidden state. Hence,
future studies regarding therapy processes for different medical disciplines must be conducted.
7.8 Conclusions
The use of a stochastic model provides a reliable classification of patient-specific information
entities with the corresponding workflow step in the treatment process. To the best of our knowledge,
this is the first approach designed to infer clinical workflows directly from HIS information entities.
There is only one similar approach available in the scientific literature, which was developed by
Huang et al., who used clinical event logs for mining clinical pathway patterns [47, 46].
Workflow recognition and the automatic classification of patient-specific information are impor-
tant for the development of assistance functions for different clinical use cases. The knowledge of
the patient’s current treatment step provides the basis for workflow assistance. With this knowledge,
clinical information systems are able to provide physicians and surgeons with only the information
necessary for a specific therapy phase such that less time is spent in searching the appropriate
information entities. A second relevant use case in daily clinical routine is the acquisition of patient-
specific documents. In existing information systems, physicians and surgeons browse through tens
or hundreds of data sets and manually search appropriate documents. It is not possible to answer
questions such as “Please give me all documents that have been created during radiation therapy”.
When each information entity is tagged with its corresponding workflow step, access to information
generated during a specific step in the treatment process can be significantly improved.
Future work will focus on improving the presented approach and integrating it into daily clinical
routines. First, the capabilities of the model must be extended. The current state of development does
not support breaks in the process in the case of treatment abortion or death, which is very important
for the use in daily clinical routines. Additionally, the time elapsed between two observations should
be incorporated into the model to support the detection of potential process phase transitions. This
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information can then be used to refine the transition and observation matrices of the model. Second,
the ability to train the model for daily use is a crucial prerequisite. This could be realized using
a feedback-based approach, in which experts correct failures of automatically tagged information
entities. Furthermore, the HMM will be integrated into oncoflow (see Section 7.4.1) to enrich
the patient-specific information with workflow information and to implement the aforementioned
clinical workflow assistance functionalities.
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Chapter 8
A concept for multidisciplinary clinical
application
The treatment process of tumor patients is supported by different stand-alone EPR and Clinical
Decision Support (CDS) systems. We developed a concept for the integration of a specialized
EPR for head and neck tumor treatment and a Digital Imaging and Communications in Medicine in
Radiotherapy (DICOM-RT) based CDS system for radiation therapy in order to improve the clinical
workflow and therapy outcome [98]. A communication interface for the exchange of information
that is only available in the respective other system will be realized. This information can then
be used for further assistance and clinical decision support functions. In the first specific scenario
radiation therapy related information such as radiation dose or tumor size are transmitted from the
CDS to the EPR to extend the information base. This information can then be used for the automatic
creation of clinical documents or retrospective clinical trial studies. The second specific use case
is the transmission of follow-up information from the EPR to the CDS system. The CDS system
uses the current patient’s anatomy and planned radiation dose distribution for the selection of other
patients that already received radiation therapy. Afterwards, the patients are grouped according to
the therapy outcome so that the physician can compare radiation parameters and therapy results
for choosing the best possible therapy for the patient. In conclusion this research project shows
that centralized information availability in tumor therapy is important for the improvement of the
patient treatment process and the development of sophisticated decision support functions.
8.1 Introduction
The therapy planning for tumor patients is a long-lasting and challenging process due to the com-
plexity of disease patterns, manifold treatment options and the involvement of different specialized
medical disciplines [99]. Actually, numerous assistance and decision support systems are used in
daily clinical routine for relieving physicians and surgeons from recurring and time-consuming
tasks as well as supporting in complex therapy planning scenarios. However, these systems do not
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integrate well into the clinical workflow, are poorly integrated into the clinical IT landscape and
have only limited possibilities for sharing patient-specific information with each other [6].
For improving the therapy planning, enhancing the possibilities to perform clinical trial studies
and quality management as well as making the patient treatment process more safe and more effi-
cient a cooperation project between the ICCAS at the Universität Leipzig and the Image Processing
and Informatics Lab (IPILab) at the University of Southern California (USC) has been established.
In the first step of the project two clinical information systems assisting physicians and surgeons
in daily clinical routine have been analyzed in detail. The goal has been the identification of new
and sophisticated solutions for systems integration, common usage of existing information and the
development of valuable assistance functions that benefit from a broader information base.
The oncoflow EPR was the first system under consideration [55]. The second system which has
been analyzed is an imaging informatics based decision support system that aims to lower radiation
dose to organs at risk surrounding the tumor, in order to reduce radiation toxicity and improve
patients’ quality of life post-treatment [100]. This system has been developed at the IPILab in
close cooperation with the Loma Linda University Medical Center (LLUMC) and the University of
California at Los Angeles (UCLA). Based on a quantified patient anatomy and a knowledge base of
existing information from retrospective treatment plans the system helps the radiotherapist to find
the best possible treatment plan parameters and the most optimal dose parameters for the patient.
In this chapter a detailed analysis of the clinical workflows, information models and assistance
functions of both information systems will be given. The analysis revealed very promising inter-
connections between the workflows and data models. Both systems depend on information entities
which are available in each of the other, so that the implementation of communication interfaces
seems to be very fruitful. Finally, a concept for systems integration and further common research
will be given.
8.1.1 Clinical workflow for head and neck tumor treatment
The treatment process for patients with head and neck tumor and the most important clinical in-
formation systems used in each process step are briefly depicted in Figure 1.1. Most patients are
referred from a general practitioner to the clinic with a suspected tumor. In a first consultation the
current medical status of the patient such as pain, medication, allergies and way of life is docu-
mented and an examination of ears, nose and throat is performed. When a tumor is furthermore
suspected the patient underwent an examination in full anesthesia, the panendoscopy, where sam-
ples from potential tumor tissue are taken. After a histopathological examination of the tissue
samples confirming the presence of a tumor the patient is discussed in the regular tumor board for
finding the best possible therapy. Common therapy options are surgical interventions, radiotherapy
or chemotherapy. After each applied therapy the patient will be discussed again in the tumor board
for results evaluation. In the case of remaining tumor tissue and further available therapy options
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the patient is scheduled for the next treatment steps. Otherwise, when no more tumors persist the
patient is released into follow-up phase.
8.1.2 Radiation therapy workflow for prostate cancer treatment
The workflow for planning and conducting radiotherapy is shown in Figure 8.1. At first the patient
is referred to the radiology department for the generation of simulated CT images. These images
are the basis for the treatment planning workflow. Afterwards, relevant organs or Region of Inter-
ests (ROIs), are manually contoured within each CT slice on a TPS. These ROIs include critical
organs and structures surrounding the tumor, as well as target definitions. Subsequently, the initial
parameters such as number and placement of radiation fields, adjustment of multi-leaf collimators,
etc. are estimated for a first computation of a dose grid. The Planning Target Volume (PTV) and
also the adjacent organs that are affected during therapy, the Organs at Risk (OAR), are depicted
in Figure 8.2. Thereafter, the resulting Dose Volume Histogramss (DVHs), isodose contours, dose
homogeneity, etc. are reviewed and re-adjusted within an iterative process until the radiation oncol-
ogist approves the treatment plan. Finally the patient receives the radiation therapy. The described
workflow is embedded into a complete tumor treatment workflow as one specific therapy option
such as depicted in Figure 1.1 and not performed stand-alone.
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Figure 8.1 – Workflow for planning and delivering radiation therapy
8.2 Methods
In this section a detailed overview about both information systems will be given. Hereby the focus
lies on the underlying workflows, information models, assistance functions and required information
entities. The first system under consideration will be oncoflow because it covers the entire patient
treatment process in oncological head and neck surgery. The workflow of the decision support
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system for radiotherapy planning will be analyzed afterwards because its workflow represents one
possibility of the therapy phase in the overall treatment process.
8.2.1 Analysis of the oncoflow information system
The clinical information system oncoflow aims to support the physician and clinical staff throughout
the entire treatment process. A crucial prerequisite is that all necessary patient-related information
is available in a centralized database. Therefore, communication interfaces to relevant clinical
information systems such as the HIS or the DTTM have been established [18, 7, 101]. These
interfaces provide an automatic import of therapy-related information into the central database
and relieve physicians and clinical staff from error-prone and time-consuming copy and paste
procedures. The underlying information model is briefly depicted in Figure 3.1 and shows the
patient-specific information groups in the oncoflow database. The tumor board protocol and follow-
up information entities are important in the scope of this project and already available in oncoflow.
Hereby the tumor board decision is the key event where radiotherapy is started. The follow-up
information contains long-term therapy outcome as well as the patient’s survival status. Missing
data in oncoflow is information generated during radiotherapy. Basically each information entity
is stored in a structured way for further electronic processing, workflow assistance in daily clinical
routine and usage in clinical trial studies or for quality management purpose. The information is
conveniently accessible for the clinical staff within a structured web interface.
The usage of oncoflow for workflow assistance such as automatic generation of clinical docu-
ments, the support of retrospective clinical trial studies or improved quality management requires a
broad information base. Information originating from anamnesis and clinical examination is impor-
tant for the following therapy decision; hence, entered manually within a structured reporting form
from the physician during this process step. The automatic data import enriches the underlying
MySQL database with additional information such as patient master data, diagnoses, histopatholog-
ical results, radiological results, tumor board decisions and follow-up information. Unfortunately,
an automatic import of therapy-related information such as intervention reports or radiotherapy
dose plans could not yet be established.
8.2.2 Analysis of the decision support system for radiation therapy
planning
The aim of the decision support system is the creation of a patient model through mathematical
quantification of relevant anatomical characteristics of patients in order to assist the clinician in
identifying the treatment parameters that are likely to yield the most optimal outcomes and help in
minimizing normal tissue complications. The underlying problem is depicted in Figure 8.2. The
PTV must receive a homogeneous radiation dose. However, the adjacent OAR should only receive
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the lowest possible dose from the overlapping radiation field. Unfortunately, the radiation field
often includes many critical structures that should ideally be spared. The likelihood of an OAR
being over-dosed varies in accordance with the volumetric spread of the OAR around the PTV. For
instance, even with the same amount of volumetric overlap between OAR1 and OAR2 with the
PTV, small shifts in radiation dose result in much more devastating effects for OAR2 as compared
to OAR1 solely based on the geometric spread of the OARs around the PTV. The system quantifies
certain patient-specific anatomical features and uses this information in refining the treatment plan
by drawing upon the knowledge base of the decision support system to identify the most optimal,
achievable dose end-points and treatment plan parameters.
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Figure 8.2 – The overlapping problem of PTV and different adjacent healthy organs during radiation treat-
ment delivery
The decision support system acquires necessary information from four main Digital Imaging
and Communications in Medicine (DICOM) files namely CT Images, DICOM-RT Structure Sets,
DICOM-RT Dose Objects and DICOM-RT Treatment Plans (see Figure 8.3, left). Information
in this context is always patient-specific; hence, each information entity is related to the patient.
A patient may have multiple studies containing multiple series objects. The CT images hereby
contain the image pixel and image plane metadata that help in registering the images in the patient
coordinate system. The structure set contains a list or sequence of ROIs defined by a name and
a number and a sequence of contours as well as associated CT images related to each ROI (see
Figure 8.3, right). Dose objects contain a three-dimensional grid where pixel values represent dose
measurements scaled by a dose grid-scaling factor, and different dose volume histograms belonging
to the different ROIs. Finally, the plan object contains different technical details belonging to the
actual treatment plan such as the amount of dose that has to be delivered to the target, maximum
allowed deviations for ensuring patient safety or parameters describing the positioning of the patient
with respect to the treatment machine. Furthermore, a knowledge object that is not part of the
DICOM standard, but rather contains information that has been gathered and calculated from the
raw DICOM data. At the moment, the database lacks follow-up information about therapy outcome,
complications and survival rates. This information is important for further assistance functions such
as proposing patients with similar anatomy with a good outcome to the radiotherapist for improved
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therapy planning.
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Figure 8.3 – left: Diagrammatic representation of the information model of the radiation therapy CDS
system; right: Exemplary representation of a RT Structure Set object
8.3 Results
A concept for the integration of oncoflow and the CDS system has been developed (see Figure 8.4).
The overall patient treatment process is depicted with blue chevrons. The workflow for radiation
therapy is depicted with red chevrons; hence, one can see that both processes integrate well. Com-
munication interfaces for sharing patient-specific information are shown as gray arrows and the
data that is relevant in the specific workflow step is described in the round-cornered rectangles left
beside the arrows.
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Figure 8.4 – Integration concept for oncoflow and the CDS system and communication interfaces with
relevant information entities that have to be exchanged
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Within this concept the CDS system is able to use additional information originating from
previously conducted therapies for improving the radiation treatment plan. After the tumor and
the adjacent organs at risk have been segmented, the radiotherapist creates the initial parameters,
plans the computation on TPS and evaluates the plan. If the radiotherapist is dissatisfied with the
plan evaluation step the CDS system is used for reducing further iterations. The system is able to
find previously treated patients with a similar anatomy. Subsequently, the CDS system will acquire
the respective therapy outcomes, complications and survival statuses from oncoflow. The radiation
therapy plans and therapy outcomes can now be linked together for assisting the radiotherapist
during the next planning iterations. Finally, the correct plan parameters are transmitted to oncoflow
for further usage e.g. for the creation of a clinical report or the discussion of the patient in the
following tumor board.
The decision support system was initially tested with proton therapy treatment planning data
for prostate cancer. However, since the anatomical variations in the tumor location and tumor-
OAR spatial relationships is very minute across patients, this system does not provide as much
benefit to prostate cancer cases as it would to cancer sites with more complicated anatomies. The
system is currently being used with head and neck cancer patients treated with conventional three-
dimensional conformal radiotherapy (3d CRT) as well as Intensity Modulated Radiation Therapy
(IMRT). Treatment planning for head and neck cancer involves a lot of small critical structures
surrounding the PTV, with a lot of variation in tumor location.
8.4 Discussion
Patient-specific information is the basis for efficient clinical workflow assistance, decision support
and personalized medicine especially in the field of tumor treatment. The both systems analyzed
in this paper support the oncological treatment process, whereby they perfectly complement one
another. The workflow for radiotherapy is a part of the whole patient treatment process. At the
moment both systems are lacking different information entities that the respective other system
owns. Oncoflow needs information about radiation therapy planning and treatment delivery that
is important for tumor board discussion, further therapy planning and outcomes analysis within
clinical studies or quality management. This information is available in the radiation therapy deci-
sion support system. The latter system in turn is able to group patient data according to anatomy,
treatment plan and outcome; hence, it is able to provide the radiotherapist a set of patients that have
already received their therapy for comparison with the current patient for finding the best therapy.
However, an important information entity in this context is the therapy outcome that is not available
to this system but inside the oncoflow database.
In the next phase of this project the decision support system will be evaluated in the field of head
and neck surgery. Therefore, communication interfaces between both systems will be established
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to facilitate the exchange of patient-specific information and improve the clinical workflow. After-
wards, therapy outcome information available in oncoflow can be used for improved radiotherapy
decision support. Radiotherapy planning information such as the radiation dose enriches the on-
coflow database and can be used for workflow and decision support or clinical trial studies. Due
to the fact that both systems are web application based on a MySQL database a final integration
of both systems and the database schemes seems appropriate eliminating redundant information
storage and the creation of a more generalized electronic patient record for personalized medicine.
8.5 Conclusions
Two different information systems with clinical decision support have been analyzed with respect
to their workflows, information models and assistance functions. The system oncoflow accompa-
nies the entire treatment process of patients with head and neck tumors and provides automatic
information import from different clinical information systems and clinical workflow support. The
second system provides decision support during prostate cancer treatment planning. The detailed
analysis of both systems revealed that they are lacking important information entities such as radio-
therapy information or patient outcome amongst others. Hence, further research between ICCAS
and IPILab in systems integration and information exchange provides a high synergy potential for
making the entire treatment process of cancer patients safer and more efficient.
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Discussion & Conclusions
9.1 Resume
The oncological patient treatment is a long-term process where physicians and surgeons decide
on complex therapies based on existing patient-specific information. Information about the actual
patient case originates from different specialized medical disciplines during the clinical diagnostics
phase. Involved are physicians performing the first consultation, radiologists conducting CT or
MRI scans, surgeons taking biopsy samples and pathologists examining the tissue samples in order
to receive a TNM classification. Some of the generated information is available in a central HIS
or PACS, some information is stored across multiple department-internal information systems or
noted in paper-based patient records. However, after clinical diagnostics physicians and surgeons
participating in the treatment process meet in regular tumor boards to discuss the best possible
therapy for the patient. The better tumor board participants are informed about the actual patient
case the better is the therapy decision they agree upon.
This work aims to improve the information management and the quality assurance in oncology.
Therefore, an analysis of the patient treatment process in oncological head and neck surgery was per-
formed. The analysis revealed that the management of patient-specific information is a challenging
task for surgeons and physicians. Existing clinical information systems are insufficiently integrated
into daily clinical routine and stored information entities are distributed across different proprietary
databases. Thus, existing information is hardly usable for further electronic processing, workflow
support, clinical studies or quality management. Hence, a web-based clinical information system
oncoflow has been developed which automatically integrates patient-specific information from dif-
ferent information systems into a multimodal digital patient model. Based on this centralized and
structured information source assistance functions supporting physicians and surgeons in daily
clinical routine and quality assurance measures were implemented. The system is a prototypical
implementation and will be extended with further functionalities in the future.
Subsequently, the system was deployed at a clinical site and used in daily clinical routine for
the documentation of first consultation results, panendoscopy reports and for the creation of tu-
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mor board invitations and tumor board protocols. Additionally, the information visualization and
seating arrangements in the meeting room were significantly improved to provide a collaborative
environment, a common knowledge base about the actual patient case and decision-making support.
A clinical study was performed in order to evaluate the advantages of the new information system
compared to the previous situation. The study revealed that the new system efficiently supports
the clinical documentation process, improves the information quality through standardized and
structured documentation forms and is finally well-accepted because of a modern and responsive
user interface.
Due to the usage of oncoflow in a productive environment for more than one year the database
contains large amounts of patient-specific information. In order to improve the information quality
in oncoflow to develop intelligent clinical assistance systems or to provide efficient access and
export of information for clinical studies and quality management tasks a sophisticated approach to
predict the current treatment step based on Markov models was developed. 40 patient data sets with
more than 2000 information entities were used to build a stochastic model which represents the
treatment process in multiple granularities. Afterwards, a leave-one-out cross validation study was
performed to evaluate the prediction rates of the model. The study proofed that this model allows to
predict the patients current treatment step based on data sets in the EPR with recognition rates up
to 90%. The workflow recognition allows clustering of patient information and to answer questions
such as “Show me all ICD10 codes which were generated during the therapy phase!”.
The oncoflow application was developed in close cooperation with physicians and surgeons from
head and neck surgery. In order to provide a more generalized solution which is not tailored to a
specific medical discipline a concept for a multidisciplinary clinical application of oncoflow was
developed. Within this concept the usage scenario was extended from a primary surgical workflow
driven application to support information exchange and integration of decision support for radiation
therapy.
9.2 Goal achievements
The goals of this work are described in detail in Section 1.4. Fortunately, with the development of
oncoflow and the TPU as well as the usage of both systems in daily clinical routine one can conclude
that these goals have been fulfilled. However, regarding the seven work packages in Section 1.4 not
all goals could be achieved completely.
9.2.1 Achievements: Information management in oncology
Goal 1 achievements The first goal was a deep understanding of the oncological patient
treatment process in head and neck surgery. The entire treatment process and information systems
which are used in each process step are depicted in Figure 1.1. A profound knowledge of all process
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steps except the therapy could be achieved. The activities, people and information systems in each
process step are described in detail in the corresponding sections for workflow assistance where the
gained knowledge is immediately transferred into assistance modules. Intraoperative workflows or
detailed information about radiotherapy or chemotherapy could not be achieved in this work.
Goal 2 achievements The next goal aimed at the centralization of important information
into one database and the development of an information system that supports physicians and
surgeons. The oncoflow information system provides an easily extensible infrastructure for clinical
workflow support and communication interfaces to relevant clinical information systems. Patient-
specific information is automatically imported where possible, acquired in a structured manner
where necessary and stored into a central database.
Regarding the requirements on EHRs listed in Table 2.1 the EPR in oncoflow provides the
demanded functionality in terms of the cancer treatment plan such as demographic information,
diagnosis documentation or tumor staging. The system is lacking information entities requested
in the category cancer treatment summary originating from the therapy phase. This is rather an
organizational problem because of lacking data export interfaces to the leading clinical information
systems than an issue with oncoflow itself and will be realized in future work. The same holds for the
oncology-specific documentation. Parts of the oncology-specific functionality such as chemother-
apy and drug management are not in the scope of this work. Other parts of this category such as
bar-coding or RFID technology are already implemented within the TPU. Also the generation of
quality metrics and other reports is possible in the current development stage to support workflow
assistance and quality assurance.
9.2.2 Achievements: Clinical workflow support
Goal 3 achievements The development of efficient workflow assistance functions was the
aim of the third goal. We developed support functions for the first consultation, panendoscopy
and follow-up documentation as well as for tumor board management and scientific evaluation.
The focus was on the assistance functions which were most favored by our clinical partners. A
prototypic implementation of these functions was developed and is still in clinical use. However,
the clinical studies performed with this modules and the experience gained through the daily usage
showed that there is still room for improvements. The system is also lacking support for therapy-
related workflow steps due to missing data. But finally, the existing assistance modules really help
physicians and surgeons in daily clinical routine and are very appreciated.
Goal 4 achievements Goal number four was the improvement of the decision-making process
during tumor board conduction. We implemented a new room concept and provide additional
information as well as immediate results documentation. The new TPU is well-accepted from
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all participating physicians and surgeons and the results documentation, invitation and protocol
mailing with oncoflow saves physicians valuable time. A second clinical discipline could be won in
May 2014. The department of maxillofacial surgery also uses oncoflow and the TPU for scheduling
their patients for tumor boards. Unfortunately, the new V-style seating arrangements persisted only
the first months and was then rearranged to the former style.
Goal 5 achievements The fifth goal was the evaluation of the new system in a clinical study.
The first part of the study was a qualitative evaluation with a questionnaire in order to evaluate the
satisfaction with the new system and to compare oncoflow with the HIS SAP i.s.h.med. The results
were very promising and oncoflow received very good ratings compared to the HIS. The second
and third part of the study focused on a quantitative evaluation in terms of usability and information
quality. The results showed that the usage of oncoflow does not consume more time and the results
also show that the information quality is much better with oncoflow.
9.2.3 Achievements: Clinical workflow recognition
Goal 6 achievements Goal number 6 aimed at the recognition of the actual process step based
on patient-specific information. Therefore, a probabilistic model based on HMMs was developed.
The model prediction rates were between 80% and 90%. Hence, this model can be used to classify
patient-specific information in the EPR and provide a more structured information base for further
clinical assistance and decision-support functions.
9.2.4 Achievements: Generalization and multidisciplinary usage
Goal 7 achievements Finally, the last goal was the extension of oncoflow to a more generalized
system which is not tailored to a specific medical discipline. Therefore, a concept was developed
to include radiation therapy decision-support and share important information in order to provide
additional support functions. The actual integration of both systems and the extension of oncoflow
to more clinical disciplines is part of future work.
9.3 Lessons learned
The development of a clinical information system that really integrates into daily clinical routine is a
challenging task. The initial idea was the integration of all patient-specific information into a central
database for realizing appropriate workflow assistance for the physician. In the first step only clinic-
internal databases developed for clinical studies and the HIS have been considered because they
contained information for every process step. Our experience showed that this information is not
sufficient at all for supporting daily clinical routine. Hence, it is important for the implementation
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of a comprehensive information model to not only rely on given information but to accompany
each process step personally in daily clinical routine. One have to talk to the physician, gather
all available questions that the physician asks the patient and examine paper-forms as well as
information systems that are used during the treatment process.
The realization of interfaces to the existing HIS was a cost-intensive and time-consuming process.
Therefore, legal agreements with the IT department and clinical directors had to be established
concerning data security and an external supplier had to be engaged that extends the HIS with the
desired data export features. The overall process until the export interfaces were working without
errors lasted about 18 months whereby lacking or error-prone data exports made up the major
issues. Faber presents different approaches for the design and implementation of EPR systems
and carefully investigates the top-down and bottom-up approach [102]. He concludes that a strict
top-down approach of the management leading the project into the right direction and a specific
user involvement in the basic process steps seem to be a good approach. This approach has been
successfully applied for the development of oncoflow. Hereby, the senior physician had the project
lead from clinical side and defined and enforced the overall project goals. On the other side the
detailed technical realization, the development of the user interface, the improvement of the user
experience as well as the integration of the system into daily clinical routine has been performed
self-reliant from ICCAS staff together with physicians from the head and neck department.
9.4 The Digital Patient Model, the Therapy Imaging and
Model Management System and oncoflow
The oncoflow IT infrastructure implements one step towards a Digital Patient Model (DPM) within
a Therapy Imaging and Model Management System (TIMMS) infrastructure [103].
A DPM is the orchestration of heterogeneous patient-specific information in order to assist
physicians and surgeons and to provide clinical decision support by using machine-learning and big
data approaches. In the scope of this work the basis for a DPM for head and neck surgery was created.
The oncoflow database integrates textual information throughout the entire treatment process from
anamnesis to follow-up consultation. This information is enriched by annotated endoscopic images
originating from the DTTM. A further building block of the DPM are 3-dimensional models of the
patients anatomy. The Dornheim Segmenter is a state-of-the-art tool that provides the creation of
3d models based on CT images, the segmentation of organs as well as precise volume measuring
of anatomical structures [13]. The integration of this information into the oncoflow system is future
work.
The TIMMS specifies basic requirements on an IT infrastructure for personalized medicine
and the digital OR. A high-performance computer network connects different engines with model
databases (see Figure 9.1). The oncoflow system already implements several aspects of a TIMMS.
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The oncoflow database in the narrower sense or the oncoflow DPM in the broader sense can be
seen as a TIMMS repository. Furthermore, the clinical workflow support in oncoflow implements
the kernel for workflow and knowledge and decision management. The structured web-based user
interface can be seen as the visualization and representation engine. The modeling engine is repre-
sented by the Dornheim Segmenter. Future work focuses on quality assurance, which also includes
verification of information entities, so that oncoflow will implement a TIMMS validation engine.
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9.5 Future work
Future developments of the oncoflow system focus on supporting the entire oncological treatment
process in head and neck surgery by implementing the lacking support for the therapy phase.
Therefore, the access to therapy-related information such as reports from surgical interventions,
radiation therapy doses and chemotherapy cycles has to be established. Subsequently, the specific
details of those workflow steps, participating physicians and information flows have to be evaluated
in detail in order to provide efficient workflow support. Thus, further physicians from different
clinical disciplines such as radiotherapists or chemotherapists may get involved in the usage of
oncoflow and provide valuable input for making the system usable in a more generalized way.
With a growing amount of patient-specific information in the database the implementation of
comprehensive evaluation features for secondary usage of the existing information for clinical trial
studies, quality assurance as well as clinical certifications becomes more important. Hence, addi-
tional effort should be spent in extending the module for scientific evaluation and export presented
in Section 4.7. Additionally, data mining and native language processing techniques are promising
research areas in order to extract valuable information from free-form text and to develop an infor-
mation base that is semantically connected. Summarized, the system must be smarter to really add
value to daily clinical routine and administrative tasks.
Finally, the generalization of the system for multidisciplinary application is a major point of
future work. This point is very important for the development of a commercial system instead of a
scientific prototype.
9.6 Conclusions
The development of oncoflow lasted three years until the state that is presented in this work was
achieved. During this time we had a tight collaboration with physicians and surgeons from the
clinic for head and neck surgery at the university medical center Leipzig. This collaboration is very
important to understand the requirements of such a system in daily clinical routine. Therefore, we
spent much time to be present during first consultations, clinical examinations, panendoscopies,
tumor boards and follow-up meetings in order to fully understand the clinical processes, see the
forms which have to be filled out and to see how the physician works and interacts with the patient.
I think, this was one major aspect why we were able to fully comprehend the clinical requirements
and to develop an information system that fits to the users needs.
Our scientific prototype is in use in daily clinical routine since March 2013, is really appreciated
by the physicians and surgeons and is steadily improved. The clinical studies and the constant
usage show that the system is really accepted by the users because of the good usability. Oncoflow
and the TPU received much attention at the worlds largest computer exhibition CeBIT 2013 in
Hannover. Saxony’s Minister-President Stanislav Tillich visited the exhibition booth and was en-
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thusiastic about our research (see Figure 9.2). The systems also received much attention from the
local newspaper “Leipziger Volkszeitung” with a great article about the new TPU (see Figure 9.3).
Oncoflow was also nominated as one of the most innovative products in the field of E-Health in the
year 2014 at the “Innovationspreis IT” which is a great achievement for this work (see Figure 9.4).
Finally, the presented systems are a great platform for further research in the field of oncology.
Oncoflow will be the information basis for sophisticated assistance and decision-support systems
due to the availability of a huge amount of patient information within a central database. A very
promising research project in this field is the DPM which aims to integrate all patient-related infor-
mation as well as scientifically based knowledge into a multi-dimensional model [104]. Eventually,
oncoflow will be available as commercial product with certification as medical product according
to the Medical Device Directive (MDD).
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Die Behandlung von Patienten mit Tumoren im Kopf-Hals-Bereich gestaltet sich als komplexer
und herausfordernder Prozess sowohl für den Patienten als auch für die behandelnden Ärzte und
Chirurgen. Zur Gewährleistung der bestmöglichen individuellen Therapie werden vor Beginn der
Behandlung zahlreiche diagnostische Verfahren durchgeführt. Hierzu zählen unter Anderem medi-
zinische bildgebende Verfahren wie z.B. Computertomographie (CT) oder Magnetresonanztomo-
graphie (MRT) sowie die Entnahme von tumorverdächtigem Gewebe während einer Panendoskopie
zur exakten Bestimmung der Tumorart (Histologie, Grading, TNM-Klassifikation nach UICC, ge-
naue Lokalisation des Primärtumors, der lokoregionären Metastasen und ggf. Fernmetastasen). Die
gewonnenen Informationen bilden anschließend die Grundlage für die Entscheidung über die durch-
zuführende Therapie und stehen in unterschiedlichen klinischen Informationssystemen sowie auf
Papierakten zur Verfügung. Leider werden die Daten im klinischen Alltag häufig nur unstruktu-
riert und schwer auffindbar präsentiert da die führenden Informationssysteme nur unzureichend in
den klinischen Arbeitsprozess integriert und untereinander schlecht vernetzt sind. Die präzise und
erschöpfende Darstellung der jeweiligen individuellen Situation und die darauf aufbauende Thera-
pieentscheidung sind aber entscheidend für die Prognose des Patienten, da der erste, gut geplante
„Schuss“ entscheidend für den weiteren Verlauf ist und nicht mehr korrigiert werden kann.
In dieser Arbeit werden neue Konzepte zur Verbesserung des Informationsmanagements im
Bereich der Kopf-Hals-Tumorbehandlung entwickelt, als prototypische Software implementiert
und im klinischen Alltag in verschiedenen Studien wissenschaftlich evaluiert.
Die Erlangung eines tiefgreifenden Verständnisses über die klinischen Abläufe sowie über be-
teiligte Informationssysteme und Datenflüsse stellte den ersten Teil der Arbeit dar. Hierfür wurden
in Gesprächen mit den klinischen Partnern die Arbeitsabläufe, am Behandlungsprozess beteilig-
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te Informationssysteme sowie die Datenflüsse detailliert dokumentiert. Die theoretisch erlangten
Grundlagen wurden durch Hospitationen bei den einzelnen Prozessschritten während des Behand-
lungsprozesses ergänzt. Die Hospitationen ermöglichten einen umfassenden Einblick in den klini-
schen Alltag und offenbarten wichtige Details in den jeweiligen Prozessschritten welche durch die
Arbeitsroutine der Ärzte und Chirurgen in den vorangegangenen Gesprächen unerwähnt blieben.
Aufbauend auf den Erkenntnissen aus der Workflowanalyse wurde das klinische Informations-
system oncoflow entwickelt. Hierfür wurden die Informationen über den klinischen Arbeitsab-
lauf bei der Behandlung von Kopf-Hals-Tumoren strukturiert und die patientenspezifischen Daten,
die während der Behandlung erhoben wurden, in ein technisches Datenmodell überführt. Die-
ses Datenmodell bildet die Grundlage bei der Entwicklung einer relationalen Datenbank die alle
behandlungsrelevanten Informationen an zentraler Stelle speichert und die persistenzschicht für
das oncoflow System darstellt. Das oncoflow System ist eine webbasierte Applikation, die es den
Ärzten und Chirurgen ermöglicht, klinikweit per Webbrowser auf alle patientenspezifischen In-
formationen zuzugreifen. Die Informationen werden dem Arzt übersichtlich präsentiert, so dass
der aktuelle Behandlungsstatus des Patienten sowie relevante Dokumente sofort ersichtlich sind.
Das oncoflow System aggregiert vollautomatisch alle patientenspezifischen Informationen aus ver-
schiedenen klinischen Informationssystemen wie z.B. dem Krankenhausinformationssystem (KIS)
oder abteilungsinternen Unterstützungssystemen und speichert diese Daten strukturiert in der inter-
nen Datenbank. Der automatische Datenimport entlastet das klinische Personal sowie Ärzte und
Chirurgen von zeitaufwändigen und fehleranfälligen Copy-Paste-Prozeduren.
Oncoflow bietet Ärzten und Chirurgen außerdem eine vielzahl von Assistenzfunktionen, um den
klinischen Arbeitsablauf, das Qualitätsmanagement oder die Durchführung von klinischen Studi-
en effizient zu unterstützen. Gleich zu Beginn des Behandlungsprozesses unterstützt das System
bei einer strukturierten Durchführung und Dokumentation der Erstanamnese sowie der klinischen
Untersuchung. In der anschließenden Panendoskopie wird die Dokumentation der Untersuchungs-
ergebnisse und das Management der medizinischen Bilddaten, die bei der Endoskopie entsthen,
unterstützt. Das Management des wöchentlichen Tumorboards wird komplett über oncoflow rea-
lisiert. Hierzu zählen unter Anderem die Einladung von Patienten zum nächsten Tumorboard, die
Erstellung der Einladungsschreiben, der automatische Versand der Tumorboardeinladungen per
EMail an die teilnehmenden Ärzte und Chirurgen, die Dokumentation der Ergebnisse sowie der
Versand der Tumorboardprotokolle. Intelligente Abfragemasken ermöglichen es dem klinischen
Personal vorhandene Informationen aus der Datenbank abzufragen und visuell aufzubereiten um
Fragestellungen für klinische Studien, das interne Qualitätsmanagement oder klinische Zertifizie-
rungen beantworten zu können.
Das System wurde anschließend in unterschiedlichen Studien evaluiert und der klinische Nutzen
in Bezug auf effizientere Arbeitsabläufe und eine verbesserte Informationsqualität gezeigt. Der
Fokus der durchgeführten Studien lag auf der Evaluation des Nutzen strukturierter Datenerhebun-
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gen durch die Verwendung eines klinischen Informationssystems was perfekt auf den täglichen
Arbeitsablauf in der Klinik angepasst ist. Während der Studien wurden Arbeitsprozesse in der Kli-
nik einerseits mit oncoflow und andererseits mit dem bisherigen KIS durchgeführt, dokumentiert
und anschließend qualitativ und quantitativ evaluiert. Die Studienergebnisse zeigen einen deutlich
strukturierten Arbeitsablauf sowie eine erheblich höhere Informationsdichte bei der Benutzung von
oncoflow verglichen mit der Benutzung des KIS.
Durch die Nutzung von oncoflow im klinischen Arbeitsalltag wurden Schwächen bei der Daten-
haltung sichtbar. Informationen enthalten unterschiedliche Metadaten wie z.B. den Zeitpunkt der
Erstellung oder den Autor. Die Abfrage von Informationen gruppiert nach dem jeweiligen Prozes-
schritt im Behandlungsprozess ist im Moment nicht möglich. Deshalb wurden im folgenden Teil
der Arbeit Machine Learning Methoden genutzt um von Daten in der elektronischen Patientenakte
auf den aktuellen Prozessschritt im Therapieprozess zu schließen. Hierfür wurden anonymisier-
te Patientendaten aus der oncoflow Datenbank herangezogen um auf Basis von Hidden Markov
Modellen (HMMs) statistische Modelle des Behandlungsprozesses zu erzeugen. Mit Hilfe der Mo-
delle lässt sich mit einer gewissen Wahrscheinlichkeit der Prozesschritt im Behandlungsprozess
bestimmen, in dem das Datum erstellt wurde. Anschließend kann der Datensatz in der Patienten-
akte um zusätzliche Prozess-Metainformationen erweitert werden die zur Entwicklung weiterer
Assistenzsysteme oder für erweiterte Datenabfragen genutzt werden können. Die Methoden wur-
den anschließend in Laborstudien wissenschaftlich evaluiert. Es konnte gezeigt werden, dass der
aktuelle Behandlungsschritt mit einer Wahrscheinlichkeit von bis zu 90% korrekt bestimmt werden
kann.
Die Methoden und Konzepte zur Verbesserung des klinischen Informationsmanagements und zur
Unterstützung von Ärzten und Chirurgen während des klinischen Behandlungsprozesses wurden
in dieser Arbeit am Beispiel der onkologischen Kopf-Hals-Chirurgie praktisch umgesetzt und eva-
luiert. Die entwickelten Methoden sind allerdings nicht auf eine spezielle klinische Fachdisziplin
beschränkt. Im letzten Teil der Arbeit werden Möglichkeiten zur Erweiterung des Systems zur
Nutzung in weiteren klinischen Fachdisziplinen am Beispiel der Strahlentherapie aufgezeigt. In
dem Konzept wird die Einbindung eines Informationssystems zur Verbesserung der Bestrahlungs-
planung in oncoflow evaluiert und es werden Vorteile für beide Systeme aufgezeigt.
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Auszeichnungen und Medienpräsenz
Abbildung 9.2 – Der Besuch des sächsischen Ministerpräsidenten Stanislav Tillich war das Highlight der
oncoflow Präsentation auf der CeBIT 2013. Jens Meier hatte die Möglichkeit dem Minis-
terpräsidenten die Vorteile des neuen Informationssystems zur Behandlung von Tumor-
patienten live zu präsentieren
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Das ist Leipzigs Zentrale 
gegen den Krebs
Spezial-Tumorboard am Uni-Klinikum ist in Betrieb – Mediziner versprechen sich bessere Therapie
Am Leipziger Uniklinikum ist gestern 
das multimediale Tumorboard in Be-
trieb gegangen. Es ist die neue Zen-
trale zur Bekämpfung von Krebs im 
Hals-Nasen-Ohren-Bereich (HNO). 
Mit dem Tumorboard können Krebs-
behandlungen im sensiblen Kopf-Hals-
Bereich besser geplant werden. Die 
Neuerung hatten die Leipziger Ärzte mit 
Informatikern des Uni-Innovationszen-
trums für Computergestützte Chirurgie 
(ICCAS) entwickelt (wir berichteten). 
„Nächste Woche dürfen wir das Tumor-
board auch auf der Cebit 2013 in Han-
nover vorstellen“, erklärte Jens Meier, 
einer der Chefentwickler im ICCAS.
„Die Technik ist schon revolutionär“, 
sagte Andreas Dietz, HNO-Chef des Uni-
Klinikums. „Besonders im Rachen-Raum 
haben wir einen extremen Zuwachs an 
Tumorarten wie Kehlkopfkrebs, Mund-
höhlen-, Zungen- oder Luftröhrenkrebs. 
Da spielen Viren eine Rolle und Lebens-
weisen wie etwa ein intensiver Tabak- 
und Alkoholgenuss. Mittlerweile stirbt 
auch jeder zweite Patient an diesen 
Krebsarten.“ Solche Erkrankungen seien 
sehr komplex, mit vielen Tücken behaf-
tet. „Und das Problem ist, dass Therapie 
und Diagnostik weltweit noch nicht so 
interdisziplinär betrachtet werden, wie 
es sein müsste. Den Krebs einfach ope-
rieren reicht hier mitunter eben nicht.“
Seit gestern läuft das in Leipzig an-
ders: Im Operativen Zentrum des Uni-
Klinikums wurde in einem Extra-Raum 
das Tumorboard-System installiert. Re-
gelmäßig versammeln sich hier die an 
der Behandlung Beteiligten: HNO-Ärzte, 
Onkologen, Strahlenmediziner, Chirur-
gen, Pathologen, Psychoonkologen...
Dann schlägt die Stunde des Tumorbo-
ards: Neben Laborbefunden, Untersu-
chungsergebnissen sowie Arztberichten 
fließen dort alle Bilddaten ein – Röntgen-
aufnahmen sowie Bilder aus dem Mag-
netresonanztomografen (MRT) und Com-
putertomografen (CT). Alle Daten eines 
Patienten werden auf den großen Moni-
toren zu dreidimensionalen Modellen 
des Tumors zusammengeführt. Dabei 
berechnet das System zugleich die Größe 
und Ausdehnung des Krebses. So lassen 
sich nun zum Beispiel Kehlkopf-Tumore 
auch von Seiten betrachten, die bislang 
nicht darstellbar waren – etwa von der 
Wirbelsäulenseite her. Alle am Tisch ver-
sammelten Experten werfen dann ihr 
geballtes Wissen in den Ring, um die op-
timalste Therapiemöglichkeit für den 
Patienten zu diskutieren.
Die weltweit einmalige HNO-Planungs-
einheit für Diagnose und Behandlung be-
kam bereits den Poster Award der Ame-
rikanischen Kopf-Hals-Gesellschaft – der 
„Oscar in der Medizintechnik“. Dietz, 
Meier und Kollegen stellen das Tumorbo-
ard nun auch den Gästen des heute be-
ginnenden dritten Workshops zur HNO-
Onkologie vor. Zu dem sind mehr als 100 
Fachkollegen und Experten für Kopf-
Hals-Tumoren aus Deutschland, Öster-
reich, Schweiz und Frankreich nach 
Leipzig gereist. Angelika Raulien
Im Leipziger Uni-Klinikum stellten Andreas Dietz (Dritter v.l.) und Andreas Böhm (Zweiter v.r.) das multimediale Tumorboard-System vor. Foto: Andreas Döring
Autobrandstifter von Gohlis 
 ab 20. März vor Gericht
Nach Anschlagserie: Drei Verhandlungstage für Prozess gegen 27-jährigen Marcus W.  
Für den Prozess gegen den mutmaßli-
chen Serienbrandstifter von Gohlis ste-
hen jetzt die Verhandlungstermine am 
Landgericht fest. Die Anklage wurde 
zur Hauptverhandlung zugelassen, teil-
te Landgerichtssprecherin Christiane 
Fernstedt mit. Ab 20. März muss sich 
Marcus W. (27) vor der 5. Strafkammer 
wegen einer Vielzahl von Brandan-
schlägen auf Pkw verantworten. Die 
Staatsanwaltschaft wirft ihm Brand-
stiftung in 26 Fällen vor, versuchte 
Brandstiftung in einem Fall sowie 
Sachbeschädigung in drei Fällen. Laut 
Anklage soll Marcus W. zwischen De-
zember 2011 und November 2012 in 
Gohlis-Nord allein 25 Pkw durch 
Brandstiftungen erheblich beschädigt 
oder zerstört haben. Ein weiteres Auto 
sei beim Versuch, es anzuzünden, be-
schädigt worden. Ein Pkw soll von dem 
Brandstifter leicht beschädigt worden 
sein. Gesamtschaden: rund 98 000 
Euro. Außerdem soll der Angeklagte in 
Gohlis-Nord eine Kellerbox in einem 
Mehrfamilienhaus und zwei Müllcon-
tainer abgefackelt haben. Schaden da-
bei: zirka 18 000 Euro.
Nach monatelangen Ermittlungen 
klickten am 2. November vorigen Jah-
res die Handschellen. Beamte des Mo-
bilen Einsatzkommandos nahmen den 
leicht alkoholisierten Täter kurz nach 
einem Brandanschlag auf einen Opel 
Corsa in der Zillstraße fest. Seither sitzt 
der Beschuldigte, der selbst in Gohlis-
Nord wohnt, in Untersuchungshaft. 
Nach Angaben der Staatsanwaltschaft 
bestreitet Marcus W., etwas mit den 
Brandstiftungen zu tun zu haben.
Die 5. Strafkammer des Landgerichts 
hat für den Prozess zunächst drei Ver-
handlungstage angesetzt. Ein Urteil 
könnte bereits am 28. März ergehen.   
 Frank Döring
Ein Werk des Feuerteufels: Am 24. Juli vorigen Jahres steht in der Sylter Straße ein 
Ford Fiesta in Flammen.  Foto: Holger Baumgärtner
ANZEIGE
Chefposten im Jugendamt:  
Stadt sucht deutschlandweit
Insider tippen auf externen Nachfolger / Stadtsprecher: Neues Angebot für Haller legitim 
Im Leipziger Rathaus wird an der Aus-
schreibung für den Chefposten des Ju-
gendamtes gearbeitet. Insider in der 
Verwaltung gingen gestern davon aus, 
dass externe Bewerber die größten 
Chancen haben, um einen wirklichen 
Neuanfang zu markieren. Die 
neu zu besetzende Stelle wird 
für das Amt in seiner derzeit 
bestehenden Größe ausge-
schrieben.
Die Modalitäten zur Aus-
schreibung legt das Personal-
amt in Absprache mit den 
Bürgermeistern fest, wobei in 
diesem besonders wichtigen 
Fall auch der Stadtrat einbe-
zogen wird, erklärte Stadt-
sprecher Matthias Hasberg. 
Deutschlandweit können sich jede 
Fachfrau, jeder Fachmann bewerben – 
und natürlich auch Mitarbeiter der 
Leipziger Stadtverwaltung, sagte Has-
berg.
Seit September 2012 soll es nach 
LVZ-Informationen mehrere Versuche 
gegeben haben, Haller zum Rückzug 
von seiner Position zu bewegen. Ar-
beitsrechtlich lag aber nichts gegen ihn 
vor, bis heute erhielt er nicht mal eine 
Abmahnung. So war die Stadt auf Hal-
lers Einverständnis mit der Beurlau-
bung angewiesen. Wahrscheinlich hat 
der 57-Jährige schon vor eini-
gen Wochen aufgegeben. Um 
die Sache aber nicht wie ein 
Wahlkampfmanöver aussehen 
zu lassen, soll die Stadtspitze 
mit dem Vollzug bewusst ge-
wartet und die Öffentlichkeit 
erst diese Woche unterrichtet 
haben, in der Oberbürgermeis-
ter Burkhard Jung (SPD) im 
Skiurlaub weilt.
Haller ist ab heute freigestellt, 
bis die Stadt für ihn einen neu-
en Job gefunden hat. So einfach kündi-
gen – das ging in dem Fall nicht. Haller 
ist nicht verbeamtet, er ist Angestellter 
der Stadtverwaltung. „Hier greift nicht 
das Beamten-, sondern das normale 
Dienstrecht, das sich vom Arbeitsrecht 
in der Wirtschaft nicht wesentlich un-
terscheidet“, so Matthias Hasberg. „Ei-
ner Kündigung haben mehrere Schritte 
bis hin zu einer Abmahnung vorauszu-
gehen. Und wie in der Wirtschaft gibt 
es auch in der Verwaltung Fälle, in de-
nen arbeitsrechtlich alles in Ordnung 
ist, der Vorgesetzte sich aber mögli-
cherweise eine andere Arbeitsweise 
oder andere Schwerpunktsetzungen 
wünscht. Ist dies nicht zu erreichen, ist 
es ein geeignetes Mittel, dem Mitarbei-
ter ein anderes Angebot zu unterbrei-
ten. Auch dies ist in der Wirtschaft ein 
übliches Verfahren.“ 
Für Siegfried Haller (SPD) war es ges-
tern der letzte Arbeitstag als Chef des 
Leipziger Jugendamtes, das er zuletzt 
so gar nicht mehr im Griff hatte. Wie 
berichtet, hatte ihn Sozial-Bürgermeis-
ter Thomas Fabian (SPD) am Vortag von 
dem Posten entbunden. Ab heute leitet 
der bisherige Vize-Amtsleiter Thomas 
Schmidt die Geschicke des für Jugend, 
Familie und Bildung zuständigen Mam-
mutressorts. Abgeschirmt von Presse-
anfragen, damit er sich einarbeiten 
kann, wie Hasberg erklärte. 
 Angelika Raulien/Jens Rometsch
Thomas 
Schmidt
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Das HNO-Tumorboard
 Um das multimediale Tumorboard, einen ??
Prototyp aus der Forschung, im Uni-Klini-
kum zu etablieren, wurde eine halbe Milli-
on Euro investiert – mit Fördergeld von 
Bund und Land.
 Von der neuen Einrichtung profitieren jähr-??
lich rund 600 Uni-HNO-Patienten.
PERSONALIE
Finanzbürgermeister Torsten Bonew (CDU) 
übernimmt Aufsichtsratsvorsitz bei Wasserwerken
Nun ist es amtlich: Finanzbür-
germeister Torsten Bonew 
(CDU) wurde am Mittwochabend 
zum Aufsichtsratschef der Kom-
munalen Wasserwerke Leipzig 
(KWL) gewählt. Der 41-Jährige 
löst Detlev Kruse ab, welcher 
seit einem Schlaganfall im Ok-
tober 2011 erkrankt ist. Die 
Vertretung übernahm Tauchas 
Bürgermeister Holger Schirmbeck (SPD).
Der Wechsel hatte sich schon ange-
deutet. Am 22. Februar wurde Kruse von 
der KWL-Gesellschafterversammlung als 
Aufsichtsratsmitglied abberufen. Zugleich 
zog Bonew in dieses Gremium ein. Er 
wünsche Kruse weiter gute Ge-
nesung, betonte Bonew gestern: 
„Die Stadt Leipzig hat ihm viel zu 
verdanken.“ Wie berichtet, soll-
ten die Chefposten in den Auf-
sichtsräten von Leipzigs Kom-
munalfirmen eigentlich nicht 
mehr mit Bürgermeistern besetzt 
werden. Grund für das Abwei-
chen von diesem Prinzip dürften 
offene Fragen im Management des Stadt-
konzerns LVV sein. Volkmar Müller (einst 
KWL-Geschäftsführer) hat dort zeitlich be-
fristet Kruses Geschäftsführer-Stelle 
inne. LVV-Geschäftsführer Josef Rahmen 
geht im April 2014 in den Ruhestand. jr
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Leipzigs Chefankläger 
wechselt nach Dresden
Es ist vollbracht: Hans 
Strobl, Chef der Leip-
ziger Staatsanwalt-
schaft, ist gestern zum 
Präsidenten des Amts-
gerichts Dresden er-
nannt worden. Damit 
endet das Gezerre um 
die seit zwei Jahren 
unbesetzte Stelle in 
der Landeshauptstadt. 
Wie berichtet, hatte 
sich der 1956 in Baden-Württemberg 
geborene Jurist um den Job beim Dres-
dener Amtsgericht beworben, war aber 
im Auswahlverfahren im Mai 2011 vom 
sächsischen Justizministerium übergan-
gen worden. Strobl reichte eine Konkur-
rentenklage ein, siegte vor Verwaltungs- 
und Oberverwaltungsgericht. Das 
Auswahlverfahren sei fehlerhaft gewe-
sen, urteilten die Richter. 
Diesen Rechtsstreit mochte Strobl 
gestern nicht kommentieren. „Ich will 
nach vorn schauen, nicht zurück“, sag-
te er gegenüber der LVZ. „Staatsanwalt 
war ich mit Leib und Seele, doch jetzt 
freue ich mich auf eine neue Aufgabe.“ 
Seit knapp drei Wochen wisse er Be-
scheid. Gestern erhielt er von Justiz-
minister Jürgen Martens (FDP), der 
Strobl „Tatkraft, ausgeprägtes Fach-
wissen und vielfältige Verwaltungser-
fahrungen“ attestierte, die Ernen-
nungsurkunde. Am 
Nachmittag verab-
schiedete er sich von 
Kollegen und Polizei-
führung in Leipzig, 
heute ab 10 Uhr tritt 
er seinen neuen Job 
an – das Amtsgericht 
Dresden zählt 376 
Mitarbeiter, darunter 
65 Richter. Es ist eine 
Rückkehr nach Hau-
se: Strobl hat in Leipzig eine Wohnung, 
sah seine Familie, die in Radebeul lebt, 
nur an den Wochenenden. 
In Erinnerung an seine Zeit als Leiten-
der Oberstaatsanwalt in Leipzig behalte 
er auch die schlimmen Mordfälle an 
Kindern, sagte er. Von 2007 bis 2009 
waren Mitja, Michelle und Corinna 
missbraucht und getötet worden. „Das 
war das Schlimmste, diese Sorge, dass 
jemand herumläuft und die Wahnvor-
stellung hat, er könne das perfekte Ver-
brechen begehen“, so Strobl. „Ich bin 
sehr, sehr froh und dankbar, dass es im-
mer gelungen ist, die Täter zu fassen.“ 
Die Stelle des Leiters der Leipziger 
Staatsanwaltschaft ist laut Justizminis-
terium gestern neu ausgeschrieben wor-
den. Bis zur Ernennung eines Nachfol-
gers führt Strobls Stellvertreterin, 
Oberstaatsanwältin Claudia Laube, die 
Amtsgeschäfte.  F. D. 
Claudia
Laube
Hans
Strobl
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Abbildung 9.3 – Zeitungsartikel aus der Leipziger Volkszeitung über das multimediale Tumorboard und
die verbesserte Entscheidungsunterstützung. Der Artikel wurde mit freundlicher Geneh-
migung des Verlages abgebildet
Publikationsverzeichnis
Karlsruhe, im März 2014
ZERTIFIKAT
BEST OF 2014
Dieses ausgezeichnete Produkt hat die Jury besonders überzeugt 
und gehört damit zur Spitzengruppe aus über 5.000 eingereichten 
Bewerbungen. Der INNOVATIONSPREIS-IT der Initiative Mittelstand 
schlägt im elften Jahr die Brücke zwischen IT-Innovationen und dem 
Mittelstand. Der Schirmherr des diesjährigen INNOVATIONSPREIS-
IT ist der Bundesverband IT-Mittelstand e.V. (BITMi).
Die Initiative Mittelstand prämiert mit dem INNOVATIONSPREIS-IT 
Firmen mit innovativen IT-Lösungen und hohem Nutzwert für den 
Mittelstand. Die Experten-Jury zeichnet in dieser Kategorie mit dem 
Prädikat BEST OF 2014 aus:
schirmherrschaft des innovationspreis-it 2014
Beate Heider  
Geschäftsleitung 
 
Rainer Kölmel  
Geschäftsleitung
 
www.innovationspreis-it.de
FIRMA
 
LÖSUNG
be a part of IT
Innovation Center Computer Assisted Surgery
oncoflow
Abbildung 9.4 – Zertifikat des “Innovationspreis IT 2014” für oncoflow als innovative Lösung im Bereich
E-Health
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